TSS:Rfhg 13826.1

Basic information about the TSS

---

TSS ID: rfhg_13826.1 Species: human Chr: chr1		Start: 156126547 End: 156126562 Strand: +
Source datasets	FANTOM5|EPD
Protocol	CAGE|TSS_database
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2226308,EH38E1387665)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000473598.6:0 AK056191:0 GeneID: 4000 HGNC/MGI_ID: HGNC:6636 UniProt_ID: P02545 Nearer transcript ids and distances: ENST00000504687.6:-2 ENST00000368297.5:-358 AK097801:-358 ENST00000675431.1:-372 ENST00000515459.5:-373 NM_001282624.2:-377 NM_001257374.3:-377 AK295390:-377 ENST00000448611.6:-387 view more...

Gene_name: LMNA Gene_symbol: LMNA Gene_synonyms: HGPS MADA Gene_source: HGNC:6636

TATA-Box annotation

---

Distance to TSS:	384
Nearest PromoterID:	NM_001257374
Entrez ID:	4000
Nearest Unigene:	Hs.594444
Nearest Refseq:	NM_005572
Nearest Ensembl:	ENSG00000160789
Gene Name:	LMNA
Gene Alias:	CDCD1|CDDC|CMD1A|CMT2B1|EMD2|FPL|FPLD|FPLD2|HGPS|IDC|LDP1|LFP|LGMD1B|LMN1|LMNC|LMNL1|MADA|PRO1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.562500
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@LMNA p2@LMNA p3@LMNA p4@LMNA p5@LMNA p6@LMNA p8@LMNA p9@LMNA
Sample		p1@LMNA	p2@LMNA	p3@LMNA	p4@LMNA	p5@LMNA	p6@LMNA	p8@LMNA	p9@LMNA
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	95.65	3.12	1.56	3.51	1.36	0.00	0.19	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	85.78	3.24	2.23	3.84	2.43	0.00	0.40	1.01
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	75.04	1.93	0.39	2.89	3.28	0.00	0.58	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	101.88	2.70	1.66	2.49	2.70	0.00	0.62	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	92.69	4.72	2.70	2.70	1.80	0.00	0.00	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	81.40	3.68	1.74	3.10	1.74	0.00	0.58	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	89.55	3.49	1.53	3.27	2.40	0.00	0.87	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	73.63	3.15	2.18	2.66	2.42	0.00	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	83.35	2.14	3.21	3.85	2.99	0.00	0.21	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	117.08	0.58	2.32	9.27	3.48	0.00	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	124.10	2.83	1.21	4.04	1.62	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	100.42	2.44	4.07	4.88	2.03	0.00	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	225.03	11.61	5.00	5.48	5.00	0.81	0.32	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	152.76	9.47	4.96	3.61	2.86	0.90	0.45	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	189.91	13.83	4.83	7.46	3.73	1.10	1.10	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	190.63	13.08	4.78	4.28	4.28	1.51	0.25	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	174.07	12.01	6.33	5.02	3.49	0.00	0.00	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	161.98	9.28	3.37	2.53	5.48	2.11	0.84	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	155.15	17.59	3.73	3.73	3.73	1.07	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	208.21	11.88	7.07	5.57	3.91	0.75	1.05	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	218.92	13.23	5.75	5.35	3.88	2.00	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	191.09	11.39	6.21	4.49	3.28	0.52	0.69	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	191.17	11.76	4.78	4.65	3.88	1.03	0.78	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	225.44	13.59	3.40	6.31	5.58	2.43	0.73	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	251.28	14.45	6.45	4.64	3.35	0.52	1.03	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	233.90	15.19	5.70	6.33	7.60	0.63	0.32	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	208.25	14.84	7.14	2.75	4.95	1.65	0.55	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	268.52	14.62	6.37	6.84	3.30	0.24	0.47	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	221.13	10.18	5.65	6.30	4.04	0.81	1.13	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	249.19	15.56	5.07	5.97	4.34	0.18	0.90	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	245.98	12.14	5.65	3.56	5.23	0.63	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	256.54	16.41	5.67	8.60	3.91	0.59	0.59	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	230.87	12.24	5.91	5.28	4.22	0.00	0.84	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	137.72	10.39	4.12	2.64	2.47	0.82	0.66	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	232.99	13.46	7.67	6.36	4.67	0.56	0.19	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	270.38	16.67	6.90	5.37	6.13	0.38	0.57	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	224.00	16.35	4.91	5.11	2.45	0.41	0.82	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	217.20	10.48	8.06	5.84	5.24	0.60	0.20	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	244.44	14.32	5.40	8.91	3.51	1.08	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	202.37	14.40	6.96	5.76	5.76	0.48	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	215.50	12.70	7.06	5.41	5.65	1.41	0.47	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	170.70	12.59	2.78	3.22	3.37	0.73	0.59	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	229.87	11.60	6.54	6.33	2.95	0.42	0.42	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	245.46	16.43	5.24	5.24	4.37	0.70	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	248.16	16.26	7.23	6.63	4.82	0.40	0.40	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	245.91	15.12	5.82	4.89	6.51	0.23	0.00	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	251.66	16.31	4.08	6.72	6.00	0.72	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	248.57	10.73	4.77	7.15	3.87	0.30	0.00	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	261.88	13.88	5.51	7.66	4.31	0.00	0.48	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	223.02	15.37	3.03	5.86	1.42	0.81	0.40	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	255.78	15.78	5.33	7.58	6.76	0.20	1.02	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	233.27	16.23	4.45	7.78	5.56	0.44	0.67	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	162.88	14.19	5.32	4.61	4.61	0.00	0.00	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	140.18	13.26	4.31	4.31	1.33	0.00	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.85	5.03	0.84	0.84	1.68	0.84	0.00	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	82.20	4.13	1.84	3.21	3.21	0.46	0.92	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	171.78	13.94	4.54	9.40	5.51	0.65	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	176.64	12.20	5.14	5.14	2.57	0.32	0.64	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	97.13	9.74	0.63	2.83	2.83	0.31	0.63	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	129.02	11.99	2.12	4.94	5.64	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	123.93	8.41	1.68	7.85	5.05	0.56	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	56.53	3.18	2.39	2.39	2.39	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	122.66	8.49	2.38	4.76	3.06	0.34	0.34	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	197.55	14.30	2.27	5.85	3.57	0.00	0.97	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	196.66	12.78	5.32	8.16	7.10	0.00	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	80.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	7.90	0.00	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	290.56	10.24	11.21	11.70	3.41	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	242.98	10.41	3.97	9.42	1.49	0.50	0.50	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	238.78	15.01	4.69	4.69	5.63	0.47	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	317.94	15.23	3.31	6.95	4.31	1.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	275.93	16.09	6.19	6.50	3.40	0.31	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	315.53	14.68	7.64	8.56	3.97	0.00	0.00	0.92
Adipocyte - breast, donor1	11376-118A8	229.50	25.66	8.08	10.29	5.54	0.16	1.11	0.79
Adipocyte - breast, donor2	11327-117E4	262.30	17.33	8.02	7.38	7.06	0.00	1.28	0.48
Adipocyte - omental, donor1	11473-119C6	170.10	18.96	7.38	8.40	5.85	0.25	0.51	0.76
Adipocyte - omental, donor2	11474-119C7	289.28	18.69	6.73	9.72	6.73	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	206.65	18.09	3.01	4.69	6.70	0.33	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	197.78	22.33	7.02	5.10	4.47	0.00	3.83	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	168.22	15.39	5.50	6.60	11.00	0.00	2.20	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	205.04	37.94	8.13	6.77	3.61	0.00	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	298.72	24.85	6.95	10.60	9.56	0.35	1.04	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	176.80	12.91	4.69	9.78	5.08	0.00	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	115.05	7.21	1.29	3.09	2.32	0.00	0.00	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	319.75	13.94	4.46	8.36	5.58	0.56	0.84	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	251.58	18.22	8.23	7.05	6.47	0.59	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	174.46	11.90	5.39	3.94	4.34	0.16	0.48	0.48
Adipocyte differentiation, day08, donor2	13023-139D8	176.22	15.49	2.90	6.78	3.23	0.00	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	233.00	11.20	4.27	2.67	6.40	0.00	0.53	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	228.70	25.04	6.68	5.01	6.12	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	261.60	13.72	7.07	12.89	9.15	0.00	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	178.33	11.30	4.02	5.78	3.77	0.00	0.50	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	233.98	13.09	3.27	3.27	5.56	0.00	0.65	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	168.37	9.74	2.13	4.26	5.48	0.00	0.30	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	192.27	20.11	9.72	7.07	3.09	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	404.84	44.11	22.59	14.34	11.47	0.72	0.36	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	161.73	15.57	4.79	5.99	2.40	1.20	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	380.50	31.84	12.23	13.31	7.38	0.00	0.72	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	500.37	33.47	8.37	13.39	11.71	0.00	1.67	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	465.54	38.42	13.35	13.56	10.48	1.03	1.03	0.62
Anulus Pulposus Cell, donor1	11248-116E6	482.42	38.79	14.30	15.45	9.38	1.83	1.72	1.14
Anulus Pulposus Cell, donor2	11463-119B5	548.84	46.78	15.18	15.92	13.22	0.98	1.96	2.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	228.69	14.38	6.29	3.59	6.29	0.45	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	219.68	16.93	4.78	5.64	4.34	0.43	0.87	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	192.62	12.84	8.56	6.42	6.42	0.00	4.28	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	217.91	15.25	6.58	2.99	6.58	0.90	1.20	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	216.26	12.65	2.53	3.79	5.06	0.00	2.53	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	184.16	18.48	7.92	5.28	3.30	0.00	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	235.22	14.62	5.52	7.15	3.57	0.32	0.65	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	203.40	18.93	3.40	4.37	6.31	0.49	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	211.42	11.88	5.94	5.34	5.34	1.19	1.78	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	206.77	16.57	4.52	8.29	4.14	0.75	2.64	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	201.74	18.87	5.08	8.71	5.08	0.00	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	170.51	21.31	5.02	3.76	5.02	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	156.66	14.83	6.75	5.60	2.47	0.49	0.66	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	191.07	17.74	8.19	9.55	1.36	2.73	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	123.35	13.42	4.07	5.73	2.41	0.60	0.15	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	232.53	18.22	6.97	6.43	7.50	0.54	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	206.13	16.82	5.10	7.18	4.91	0.38	1.32	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	199.13	22.72	7.22	5.61	4.54	0.53	0.53	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	233.13	23.41	6.83	7.80	7.80	0.98	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	175.31	16.09	6.47	5.47	3.98	0.66	0.66	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	199.32	27.62	6.00	9.61	4.80	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	290.29	24.78	3.54	17.70	0.00	0.00	3.54	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	161.92	17.15	6.00	3.43	3.43	0.51	0.34	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	192.97	33.56	4.19	4.19	8.39	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	246.60	14.56	5.83	7.77	5.83	0.00	0.49	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	204.14	18.59	5.31	5.31	4.17	0.38	3.04	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	196.24	14.54	7.27	6.06	8.48	0.00	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	228.01	18.24	3.99	3.99	6.27	0.57	0.57	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	191.97	20.95	5.34	6.20	5.77	0.21	1.71	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	203.12	16.00	6.97	6.19	5.16	1.55	1.03	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	236.01	21.58	5.63	4.22	4.22	0.94	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	177.50	18.33	5.14	6.75	3.22	0.00	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	210.47	14.27	4.28	8.56	2.85	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	232.23	19.89	5.26	4.09	7.60	0.58	1.17	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	191.78	16.26	3.01	5.12	4.52	0.90	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	254.23	13.07	8.32	8.32	4.75	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	249.70	19.33	8.65	5.59	3.05	1.53	1.53	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	186.18	14.26	5.86	5.60	1.27	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	185.53	17.79	4.45	5.72	2.54	0.00	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	225.69	22.87	7.77	7.77	4.32	1.29	0.43	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	181.41	19.26	4.66	4.87	2.96	0.85	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	187.33	17.11	6.96	6.38	3.77	0.58	1.74	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	229.57	15.12	5.67	5.67	3.78	1.89	0.94	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	183.09	14.75	5.76	6.10	4.24	0.34	0.34	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	178.36	20.85	11.58	2.32	2.32	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	306.32	29.58	6.34	6.34	6.34	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	185.68	13.51	5.79	5.79	3.22	0.64	0.86	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	236.45	17.45	7.22	5.41	4.81	0.60	1.20	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	227.44	18.95	4.37	7.29	3.64	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	187.35	17.47	6.67	6.21	2.99	0.92	0.23	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	204.02	15.30	5.10	5.10	0.00	2.55	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	118.98	11.19	7.88	4.32	2.80	0.76	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	195.91	17.34	7.84	4.75	2.89	0.41	0.83	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	162.49	14.99	6.43	5.81	3.37	0.61	0.31	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	205.55	15.77	7.65	5.74	6.69	0.48	0.48	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	171.18	12.42	5.77	7.76	4.88	0.00	1.11	2.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	158.68	16.78	13.73	1.53	1.53	0.00	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	187.77	12.19	3.88	3.88	8.31	1.11	1.66	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	162.32	15.89	5.03	5.03	4.77	0.53	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	165.37	13.08	4.72	6.18	4.36	0.36	1.45	0.00
Astrocyte - cerebellum, donor1	11500-119F6	287.51	26.16	11.79	10.32	8.47	0.25	0.49	1.23
Astrocyte - cerebellum, donor2	11580-120F5	466.58	45.70	19.00	15.40	13.69	0.34	0.86	1.54
Astrocyte - cerebellum, donor3	11661-122F5	198.63	10.70	3.99	7.13	4.61	0.21	0.21	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	111.20	3.49	2.44	5.58	2.44	0.00	0.00	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	238.45	17.63	8.90	11.00	6.96	0.65	1.13	1.78
Astrocyte - cerebral cortex, donor3	11392-118C6	179.74	10.74	4.33	6.26	4.62	0.75	0.30	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	87.16	3.10	1.15	2.64	2.41	0.11	0.00	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	74.17	2.51	1.13	2.13	2.13	0.13	0.00	0.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	54.62	2.28	1.14	2.16	1.93	0.00	0.11	0.23
Basophils, donor1	12241-129G9	109.84	27.98	8.63	4.71	6.54	17.26	0.00	0.00
Basophils, donor2	12242-129H1	141.07	30.31	14.07	12.99	7.94	14.43	0.00	0.00
Basophils, donor3	12243-129H2	183.01	38.66	23.67	16.90	10.73	11.91	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	337.63	55.63	16.39	10.56	5.61	0.00	1.29	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	575.14	65.38	22.40	22.40	14.63	0.00	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	538.02	35.87	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	332.66	50.21	26.99	16.32	6.90	0.00	1.88	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	391.78	43.88	18.51	15.60	8.94	0.21	1.46	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	235.59	35.23	15.43	12.44	6.45	0.23	1.61	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	282.69	26.99	12.96	6.48	6.84	0.18	1.62	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	23.34	1.60	0.64	0.96	0.96	2.56	0.00	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	48.47	16.34	10.71	7.33	2.82	5.07	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	96.33	17.82	11.88	7.80	5.75	9.65	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	116.35	30.08	18.66	12.51	6.81	22.83	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	78.97	3.11	1.13	1.13	1.98	0.00	0.57	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	84.15	5.69	1.14	0.76	1.52	0.00	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	68.38	3.29	0.33	0.33	1.31	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	389.99	39.90	19.51	23.56	12.58	4.48	1.30	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	315.02	26.25	10.86	16.60	9.96	3.02	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	436.36	40.03	14.21	17.53	7.82	3.32	1.42	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	341.49	29.63	16.74	17.74	7.70	4.02	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	299.75	29.26	14.08	14.63	5.80	0.83	0.55	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	363.71	30.00	14.88	19.59	8.18	4.71	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	242.01	11.75	8.62	7.83	3.92	2.74	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	263.69	18.16	10.33	8.90	4.45	2.67	0.71	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	298.37	22.63	7.83	4.13	3.48	2.39	1.09	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	256.37	17.09	9.60	11.00	6.09	3.28	0.94	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	255.04	17.42	8.98	6.86	3.70	2.64	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	376.07	26.62	15.53	9.98	9.98	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	355.36	37.63	19.34	16.06	11.01	2.53	2.23	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	333.05	29.93	12.37	11.97	7.38	2.00	0.40	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	361.85	33.31	15.61	8.95	6.87	2.71	1.87	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	559.61	39.58	19.90	16.70	9.38	2.29	2.06	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	379.34	34.38	14.70	11.99	7.01	1.81	0.68	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	556.49	36.23	17.46	9.17	7.86	1.31	1.31	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	251.51	19.37	7.53	13.72	6.46	3.50	0.81	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	266.05	23.55	9.07	13.26	9.25	6.28	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	358.96	24.83	11.36	9.68	6.31	5.89	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	343.54	26.82	12.86	14.51	8.27	2.57	1.65	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	323.38	22.19	11.62	6.69	6.69	2.47	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	434.78	19.74	12.72	11.85	8.77	1.75	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	243.77	13.78	8.54	8.20	5.41	1.74	1.05	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	266.12	14.50	7.06	8.18	4.83	4.46	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	292.72	22.85	9.92	6.04	4.74	4.31	1.08	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	300.97	21.29	10.24	10.24	5.73	0.82	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	254.75	20.63	6.95	7.65	5.10	2.78	0.93	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	319.22	25.06	9.28	9.51	6.03	0.70	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	21.14	3.71	1.96	1.74	1.96	5.45	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	15.94	3.93	1.85	1.15	0.69	4.85	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	9.53	1.73	2.17	0.87	0.22	4.77	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	32.70	4.98	2.96	2.49	2.49	3.43	0.47	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	14.67	3.84	2.10	2.10	1.40	3.67	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	5.80	1.78	0.22	0.22	0.67	2.45	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	11.74	2.04	2.30	0.77	2.04	2.30	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	2.63	0.66	0.00	0.22	0.00	0.44	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	1.26	0.21	0.63	0.21	0.21	1.26	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	8.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	4.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	3.73	0.00	0.00	0.00	0.53	0.53	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	2.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4.91	0.00	0.00	0.00	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.84	0.00	0.00	0.78	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	47.67	3.29	1.64	3.29	4.93	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	73.99	3.63	1.45	4.35	5.08	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	76.23	5.55	6.56	4.54	8.08	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	188.29	15.76	3.23	5.25	9.70	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	196.15	12.78	2.40	6.39	5.19	0.00	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	171.69	20.08	9.04	11.04	6.02	4.02	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	193.82	23.60	12.36	11.24	15.17	1.69	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	42.08	5.26	0.75	1.50	1.50	0.00	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	38.56	3.16	0.90	1.13	2.03	0.68	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	289.57	32.14	20.71	15.00	17.50	0.71	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	590.32	53.89	39.80	23.88	30.62	4.90	2.45	0.00
CD4+ T Cells, donor3	11382-118B5	371.79	33.55	23.48	17.69	24.09	1.83	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	3.83	0.26	0.00	0.00	0.51	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	3.37	0.22	0.22	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	2.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	26.55	0.95	0.95	1.42	1.90	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	16.15	1.40	0.00	2.11	2.11	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	13.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	26.30	0.58	0.29	0.72	1.73	0.14	0.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	32.20	1.19	0.51	2.20	1.02	0.00	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	29.18	1.29	1.13	2.90	2.10	0.16	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	210.25	11.21	6.72	6.72	11.66	0.45	1.34	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	151.98	10.48	4.54	10.13	11.18	0.00	1.40	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	110.44	7.48	3.08	3.52	6.16	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2.53	0.84	0.00	0.00	0.42	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	7.48	0.00	0.21	0.00	0.62	0.21	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	6.68	0.33	0.00	1.00	1.34	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	6.53	0.27	0.00	0.27	0.27	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.22	0.00	0.00	0.54	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	3.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	16.13	0.93	0.19	0.93	0.56	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	15.38	0.43	0.22	1.08	0.22	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	9.67	0.00	0.00	0.42	0.63	0.00	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	88.99	7.08	5.06	2.02	6.07	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	75.39	5.20	4.33	5.20	7.37	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	52.73	3.92	0.87	0.87	3.05	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	14.35	0.49	0.49	0.00	0.99	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	6.46	0.00	0.92	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	9.77	1.40	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	14.68	0.28	0.28	0.28	0.00	0.28	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	10.80	0.74	0.25	0.25	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	18.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	21.13	1.43	0.36	0.36	1.43	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	12.46	0.00	0.00	0.00	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	275.99	38.31	26.19	16.37	14.41	1.96	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	446.01	67.58	34.54	25.15	29.28	2.63	2.63	0.00
CD8+ T Cells, donor3	11383-118B6	274.20	28.03	22.98	14.14	15.65	1.51	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	313.35	13.08	6.65	6.65	5.28	0.23	0.69	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	269.36	14.86	4.31	5.51	3.59	0.48	1.44	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	238.30	16.69	5.20	4.38	5.20	0.27	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	217.05	16.51	3.30	6.30	4.20	0.30	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	319.42	20.64	4.80	8.16	7.20	0.48	0.96	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	280.14	15.01	5.91	7.05	6.59	0.23	1.14	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	204.46	13.04	3.69	3.48	5.00	0.00	0.65	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	206.09	9.21	4.47	6.58	5.00	0.26	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	192.77	11.73	2.35	3.28	3.05	0.00	0.94	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	133.13	9.36	3.02	4.23	1.81	0.30	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	137.70	5.23	2.61	4.07	2.32	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	138.81	5.86	2.66	4.00	2.93	0.00	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	525.30	16.63	7.88	5.69	5.69	2.19	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	479.57	16.40	7.74	5.47	5.92	1.82	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	537.77	15.66	5.97	6.71	5.97	5.22	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	317.66	13.69	5.40	6.48	4.32	0.36	1.08	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	286.28	12.95	6.91	7.77	4.60	0.00	0.86	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	278.12	16.03	6.36	7.07	4.48	0.00	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	205.67	8.87	5.39	5.07	2.85	0.00	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	248.20	12.61	3.08	4.92	2.77	0.00	0.62	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	213.83	10.90	1.60	5.77	2.89	0.00	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	168.67	9.18	2.29	5.74	5.74	0.00	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	181.29	9.85	3.55	7.49	2.76	0.00	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	166.41	14.37	4.54	6.05	9.08	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	496.23	15.26	3.21	5.62	7.23	1.61	3.21	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	479.11	14.69	9.79	6.99	5.60	2.80	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	559.98	10.02	3.01	7.01	4.01	3.01	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	442.31	69.45	5.48	14.62	14.62	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	155.14	17.29	3.46	5.43	6.42	0.49	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	164.48	11.47	4.74	6.21	5.16	0.53	0.32	0.53
Chondrocyte - de diff, donor1	11261-116G1	497.47	49.57	19.76	13.17	9.71	0.00	1.04	0.35
Chondrocyte - de diff, donor2	11338-117F6	431.78	34.47	9.24	12.79	6.40	0.71	0.00	2.49
Chondrocyte - de diff, donor3	11410-118E6	422.58	30.95	9.44	12.06	6.94	0.34	2.28	1.37
Chondrocyte - re diff, donor2	11339-117F7	196.06	16.11	4.48	10.74	6.27	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	310.58	22.24	7.68	14.15	2.83	0.81	2.02	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	129.68	11.13	4.71	6.77	4.13	0.34	0.57	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	162.68	15.60	4.70	12.61	4.70	0.00	0.86	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	132.22	11.50	4.78	6.19	3.72	0.53	0.53	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	146.54	8.07	2.20	3.48	2.75	0.18	0.18	1.01
Corneal Epithelial Cells, donor1	11526-119I5	384.91	54.67	20.20	14.27	7.47	0.00	0.66	0.22
Corneal Epithelial Cells, donor2	11606-120I4	552.87	85.32	38.68	26.16	12.51	0.00	3.41	0.00
Corneal Epithelial Cells, donor3	11687-122I4	458.86	75.67	28.63	18.92	14.06	0.00	1.28	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	80.07	12.88	1.98	2.31	1.98	0.00	0.17	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	78.54	11.99	2.84	2.21	2.84	0.00	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	100.07	10.35	3.45	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	109.50	11.12	2.70	4.10	2.59	0.00	0.32	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	9.91	4.78	2.05	1.37	1.71	1.02	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	16.97	5.22	3.92	1.96	0.65	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	17.42	2.90	0.48	0.48	0.97	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	357.72	35.36	17.68	15.84	8.51	0.17	0.33	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	390.79	40.49	14.08	11.15	5.87	0.00	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	381.49	29.13	11.03	9.90	6.50	0.00	0.57	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	396.72	33.03	15.33	12.19	7.47	0.00	2.36	0.00
Endothelial Cells - Artery, donor1	11264-116G4	386.57	27.92	9.89	12.51	6.11	0.00	1.45	0.29
Endothelial Cells - Artery, donor2	11341-117F9	375.74	39.06	12.94	16.00	8.23	0.00	1.65	1.18
Endothelial Cells - Artery, donor3	11413-118E9	413.03	35.76	18.58	14.73	5.96	0.88	1.40	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	232.74	18.62	8.20	6.43	3.99	0.00	0.89	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	163.39	11.87	6.09	6.39	3.96	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	108.53	5.07	1.69	3.95	1.41	0.00	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	253.75	27.63	15.15	10.99	6.24	0.30	0.59	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	190.56	18.22	9.89	9.89	4.69	0.00	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	214.24	14.18	7.23	7.94	3.97	0.14	0.57	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	292.89	36.41	12.40	9.20	7.20	0.00	0.40	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	260.49	24.11	8.39	8.39	8.39	0.00	2.10	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	260.30	19.01	10.44	11.68	6.46	0.00	0.50	1.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	243.99	18.47	7.82	10.86	5.43	0.00	0.22	0.87
Endothelial Cells - Umbilical vein, donor3	11400-118D5	267.83	21.01	10.63	11.97	8.30	0.00	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	431.12	30.71	14.79	12.51	11.38	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	436.56	41.91	18.86	13.27	9.08	0.70	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	380.11	32.81	15.70	16.49	9.89	0.16	1.10	0.94
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	21.45	6.60	0.00	3.30	4.95	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	49.94	17.83	10.70	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	320.07	41.54	13.19	14.17	3.66	0.00	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	307.86	56.16	12.48	12.48	4.16	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	422.99	48.81	32.54	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	302.96	29.15	15.19	12.32	9.85	0.82	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	203.87	23.87	8.54	6.90	5.04	0.22	1.75	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	389.47	31.42	14.30	11.92	7.80	0.11	1.08	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	318.24	33.59	15.04	14.31	6.67	0.12	1.33	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	441.89	59.91	21.70	20.47	8.32	3.82	1.36	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	320.20	27.63	9.49	8.96	6.96	0.53	1.69	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	899.56	53.75	15.81	17.39	11.86	1.05	1.84	1.32
Fibroblast - Aortic Adventitial, donor3	11401-118D6	515.24	42.19	14.28	17.61	9.97	0.00	0.66	0.00
Fibroblast - Cardiac, donor1	11268-116G8	398.74	35.84	6.80	11.79	8.62	0.91	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	312.27	18.95	7.58	11.37	7.58	1.52	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	268.59	26.34	9.62	12.30	6.31	0.63	1.10	0.47
Fibroblast - Cardiac, donor4	11452-119A3	160.95	13.94	3.94	5.76	4.24	0.30	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	207.23	19.42	8.88	10.66	6.35	0.25	1.27	0.25
Fibroblast - Cardiac, donor6	11460-119B2	242.40	25.01	12.73	13.19	6.82	0.45	1.52	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	171.64	14.20	4.82	6.16	4.02	0.13	0.54	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	218.30	17.26	4.31	9.92	6.47	0.00	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	153.80	13.18	4.39	4.39	2.93	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	375.94	29.29	15.22	16.14	10.38	0.23	0.69	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	292.91	24.08	8.65	8.14	7.12	0.68	0.68	1.02
Fibroblast - Dermal, donor1	11269-116G9	618.41	41.09	16.20	9.39	8.45	0.94	1.88	0.47
Fibroblast - Dermal, donor2	11346-117G5	644.31	48.11	19.81	20.75	12.26	0.47	2.36	0.00
Fibroblast - Dermal, donor3	11418-118F5	580.37	50.65	16.92	15.23	9.55	0.97	1.81	0.24
Fibroblast - Dermal, donor4	11450-119A1	472.98	39.68	19.56	17.86	8.93	0.45	2.37	0.57
Fibroblast - Dermal, donor5	11454-119A5	545.52	38.38	24.60	23.90	13.43	0.52	1.40	0.87
Fibroblast - Dermal, donor6	11458-119A9	576.44	48.40	24.85	24.04	12.99	1.30	1.30	0.65
Fibroblast - Gingival, donor1	11237-116D4	486.22	30.61	14.16	9.58	7.29	0.83	1.46	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	961.80	56.07	21.75	17.82	10.74	1.31	2.10	1.31
Fibroblast - Gingival, donor2	11318-117D4	688.97	41.51	20.95	16.34	12.65	1.19	2.64	0.40
Fibroblast - Gingival, donor3	11394-118C8	541.06	32.10	12.28	10.54	8.41	0.87	0.97	0.97
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	475.81	36.36	9.35	13.51	6.23	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	466.41	20.97	12.16	11.28	8.63	0.18	3.88	1.76
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	817.05	48.02	23.38	20.42	12.47	0.47	2.96	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	925.77	53.82	23.12	15.01	9.20	1.08	2.98	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	1228.37	54.70	23.64	17.29	15.53	1.76	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	944.89	54.40	21.21	16.09	11.55	1.17	2.34	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	844.85	55.22	21.68	16.77	9.68	1.77	3.27	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	731.54	60.66	24.57	22.49	9.65	1.65	1.21	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	742.21	22.89	5.43	9.10	10.57	1.03	1.76	3.23
Fibroblast - Lung, donor1	11270-116H1	558.69	40.78	8.16	25.83	8.16	1.36	2.72	1.36
Fibroblast - Lung, donor2	11347-117G6	428.25	32.83	19.40	14.92	4.48	0.00	2.98	2.98
Fibroblast - Lung, donor3	11419-118F6	636.27	59.51	21.10	23.42	16.25	1.90	4.01	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	505.64	67.47	14.99	12.50	10.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	351.06	36.36	13.99	6.99	6.99	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	312.34	36.66	8.96	12.31	8.96	0.28	0.84	0.00
Fibroblast - Mammary, donor1	11540-120B1	341.42	40.19	15.83	11.77	9.34	0.41	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	507.26	47.93	3.99	19.97	15.98	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	244.21	29.78	17.87	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	622.85	48.69	19.20	19.20	10.28	0.19	0.58	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	565.62	38.98	17.44	18.96	12.13	0.46	1.82	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	410.33	33.96	10.40	10.40	6.12	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	859.03	41.98	12.98	11.07	8.40	0.00	0.76	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	629.89	43.20	15.39	17.28	10.80	1.08	6.21	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	481.29	19.95	9.74	13.22	8.47	0.35	1.28	0.81
Fibroblast - Pulmonary Artery, donor1	11250-116E8	258.87	29.62	13.93	12.82	6.74	0.22	0.88	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	360.46	35.76	11.38	8.74	6.50	0.00	0.41	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	674.22	47.44	20.05	19.38	14.03	0.67	2.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	657.49	45.47	17.40	19.77	9.09	0.79	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	1742.17	109.54	43.26	30.36	20.04	1.79	2.38	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	324.33	17.05	6.93	8.17	5.86	0.18	0.53	1.42
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	315.14	27.20	9.07	9.26	5.52	0.20	0.20	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1443.20	114.32	46.93	32.49	17.15	6.32	2.71	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	408.06	37.24	10.80	9.72	5.07	0.32	0.43	1.30
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	1599.43	88.32	31.63	24.30	21.01	2.28	3.80	0.51
Fibroblast - skin normal, donor1	11553-120C5	473.86	33.80	10.17	8.37	4.76	0.82	0.33	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	1195.82	81.00	35.69	22.86	11.43	4.21	0.80	0.00
Fibroblast - skin normal, donor2	11561-120D4	494.37	42.50	15.67	10.95	7.03	0.60	2.01	1.81
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	2329.95	150.21	61.66	44.43	28.71	2.72	5.74	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	341.49	23.69	8.12	7.87	4.31	0.41	1.16	1.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	358.83	29.57	8.55	9.06	6.15	0.51	0.85	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	1191.55	89.33	33.50	21.68	20.69	2.30	1.64	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	450.48	49.53	17.90	13.63	7.78	0.43	1.28	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	706.60	59.54	21.09	17.54	9.28	0.67	2.19	1.01
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	185.05	17.09	4.39	4.86	3.92	0.63	1.41	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	531.84	66.48	0.00	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	413.98	35.73	6.97	12.20	11.33	0.00	0.87	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	217.74	25.31	10.57	5.89	3.81	0.35	0.69	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	192.58	22.64	10.41	5.20	3.12	0.00	0.52	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	196.49	19.42	7.41	5.37	3.07	0.00	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	53.59	4.59	0.77	0.77	3.06	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	52.32	2.55	1.28	3.19	1.91	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	32.23	1.14	0.57	0.29	2.28	0.00	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	9.93	0.83	0.28	0.83	0.83	0.00	0.00	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	18.95	1.60	0.68	1.14	1.83	0.00	0.23	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	32.30	1.19	0.99	1.98	1.19	0.20	0.59	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	9.52	0.79	0.79	1.06	0.00	0.00	0.00	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	39.46	1.96	0.65	0.33	0.00	0.00	0.00	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	42.90	3.10	0.44	1.77	0.44	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	41.12	1.84	0.57	1.41	0.85	0.00	0.00	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	76.47	3.45	1.72	1.72	1.23	0.00	0.12	0.86
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	47.82	2.95	0.27	1.07	1.88	0.00	0.81	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	145.20	8.05	2.85	6.07	2.60	0.00	0.12	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	172.06	8.44	4.57	7.75	5.54	0.00	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	111.61	6.51	2.85	6.10	2.64	0.00	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	165.43	7.53	2.74	4.79	2.97	0.68	0.46	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	216.99	9.72	4.48	4.73	3.61	0.00	0.50	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	183.17	9.62	3.93	4.37	2.84	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	117.31	4.73	2.66	4.14	2.36	0.30	0.59	1.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	109.84	4.61	2.23	3.97	2.54	0.16	0.79	1.27
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	97.41	6.70	2.68	1.56	2.23	0.00	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	178.45	5.44	3.02	3.63	3.83	0.20	0.40	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	155.73	5.60	2.71	4.75	2.88	0.00	0.34	1.87
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	108.98	7.36	3.10	3.01	1.95	0.09	0.18	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	164.10	5.93	3.43	4.79	3.75	0.10	0.21	2.19
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	158.31	5.46	2.22	5.29	4.95	0.34	0.00	1.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	167.97	5.31	2.77	5.31	3.65	0.11	0.33	1.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	92.85	4.83	2.91	3.49	2.58	0.08	0.25	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	92.90	5.31	1.43	3.06	2.04	0.00	0.00	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	184.85	4.95	3.30	4.33	5.57	0.00	0.21	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	161.87	5.07	3.00	4.27	3.23	0.00	0.35	3.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	168.43	8.00	4.17	6.67	3.17	0.00	0.33	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	191.11	7.05	2.42	2.65	7.05	0.44	0.66	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	188.55	5.29	3.20	4.06	5.17	0.25	0.25	1.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	128.22	6.97	2.76	4.54	2.11	0.00	0.16	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	157.79	8.34	3.21	4.17	4.17	0.00	0.00	1.92
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	253.56	9.29	5.31	8.34	5.31	0.09	0.66	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	181.43	10.28	3.95	6.80	3.95	0.00	0.79	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	281.59	10.95	4.26	5.47	4.56	0.61	1.22	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	301.18	11.92	7.53	8.05	4.81	0.21	0.84	1.57
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	169.50	7.68	2.85	5.93	3.73	0.00	0.66	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	263.15	8.14	3.09	5.89	3.93	0.56	0.56	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	358.77	13.70	5.00	8.98	9.07	0.28	0.83	1.30
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	253.23	11.50	4.28	6.69	6.95	0.53	0.00	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	388.63	20.66	7.04	10.10	9.03	0.15	0.31	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	383.69	16.06	6.22	12.69	9.20	0.13	0.91	0.91
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	170.23	8.13	2.98	2.98	5.15	0.00	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	342.52	7.56	4.42	5.16	5.53	1.47	1.29	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	346.08	8.99	6.14	7.68	5.26	0.44	0.88	1.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	123.97	6.94	4.96	2.98	0.99	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	437.03	19.00	8.18	9.37	6.86	0.13	0.66	1.58
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	588.53	20.98	12.11	9.89	8.07	0.81	1.01	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	87.69	2.29	1.52	1.27	2.29	0.25	0.00	2.54
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	23.49	1.19	0.40	1.00	1.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	40.83	1.39	0.46	0.46	0.77	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	22.50	0.41	0.82	1.02	0.61	0.00	0.00	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	18.46	1.25	0.00	1.25	0.63	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	12.15	0.57	0.00	1.70	1.13	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	16.14	0.92	0.00	0.00	0.46	0.00	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	4.95	2.47	2.47	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	33.27	1.93	1.93	2.71	2.32	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	57.76	6.42	0.00	0.00	1.60	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	34.78	0.00	0.00	1.74	1.74	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	21.48	2.28	0.65	1.30	0.65	0.00	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	18.94	0.41	0.00	0.82	0.82	0.00	0.41	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	0.00	0.00	6.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	13.42	0.84	0.00	1.68	0.00	0.00	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	25.82	2.29	0.33	0.33	1.31	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	15.94	1.68	0.84	0.84	2.52	0.00	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	16.86	0.00	0.64	1.27	0.64	0.00	0.00	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	17.32	1.36	0.34	0.68	0.34	0.00	0.34	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	20.88	2.09	0.00	0.00	0.00	0.00	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	16.61	0.57	0.00	0.57	0.00	0.00	1.15	3.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	25.16	0.89	0.30	0.59	1.48	0.00	0.30	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	32.19	3.39	0.00	0.00	0.00	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	26.51	2.07	0.83	0.83	0.83	0.00	0.00	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.96	0.69	0.23	0.46	0.00	0.00	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	84.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	21.14	1.15	0.00	0.00	0.38	0.00	0.00	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	32.27	2.61	0.65	0.98	0.65	0.00	0.00	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	52.17	2.01	1.34	2.68	2.01	0.00	0.67	2.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	25.04	1.16	0.39	0.77	0.00	0.00	0.00	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	56.49	2.05	2.40	2.05	0.34	0.00	0.34	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	2.48	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	29.73	0.47	0.00	0.94	0.47	0.00	0.00	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	36.81	1.21	1.81	0.60	0.00	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	42.73	2.54	0.00	0.51	1.02	0.00	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	27.12	0.00	0.40	0.80	1.20	0.00	0.00	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	26.64	2.47	0.99	0.00	0.49	0.00	0.49	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	40.13	3.54	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	30.92	1.17	0.00	0.58	0.00	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	29.84	0.88	0.44	0.44	1.32	0.00	0.88	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	44.93	0.85	1.70	0.00	0.85	1.70	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	65.06	0.60	1.79	2.39	0.60	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	47.07	0.49	0.97	0.49	1.46	0.49	0.00	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	497.61	39.95	12.55	4.57	6.85	2.28	4.57	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	580.06	44.91	15.39	16.22	11.64	0.83	2.49	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	1197.54	79.84	40.48	24.74	12.37	3.37	3.37	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	287.35	31.72	7.93	5.39	4.44	0.32	2.22	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	434.45	42.61	7.10	10.44	7.94	0.00	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	305.89	33.77	12.30	10.44	10.21	0.12	1.62	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	306.88	31.40	13.00	11.14	10.80	0.34	0.84	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	248.89	27.76	9.78	12.29	6.14	0.00	0.68	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	313.06	32.36	13.88	11.04	9.40	0.00	1.42	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	308.83	30.73	12.68	8.81	9.67	0.00	1.07	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	260.71	27.56	10.12	5.60	6.89	0.00	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	316.70	29.76	10.83	8.72	10.21	0.12	1.00	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	287.69	28.31	8.92	9.09	5.83	0.51	1.20	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	248.93	33.32	10.89	8.97	8.01	0.64	1.28	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	328.50	12.87	8.95	8.95	8.95	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	267.90	18.61	10.82	13.42	8.22	0.87	0.00	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	388.64	18.51	2.64	10.58	2.64	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	322.74	25.40	5.64	14.46	7.05	0.00	0.35	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	409.03	25.43	10.90	12.35	12.35	0.00	1.45	3.63
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	268.38	25.00	11.01	10.84	7.69	0.35	1.05	0.52
Hepatocyte, donor1	11523-119I2	111.38	4.84	4.84	2.42	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	131.44	5.39	1.08	2.15	3.23	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	122.71	11.04	1.23	4.29	1.84	0.00	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	80.22	1.92	0.87	0.35	0.87	0.00	0.35	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	113.33	14.00	3.57	6.17	3.29	0.27	0.82	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	289.73	25.47	19.10	12.74	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	287.04	13.35	0.00	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	406.25	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	220.12	16.61	2.77	6.92	11.08	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	237.75	17.52	5.01	5.01	15.02	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	367.92	35.60	11.87	23.74	47.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	222.97	7.69	2.56	20.50	10.25	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	260.53	13.71	4.57	9.14	18.28	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	259.89	8.12	1.62	14.62	11.37	0.00	1.62	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	240.09	3.33	5.00	6.67	5.00	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	243.25	18.15	10.89	3.63	18.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	300.43	10.59	3.97	11.91	5.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	219.51	11.09	2.22	8.87	13.30	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	356.20	26.19	10.48	10.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	189.59	10.71	3.15	10.71	6.30	0.00	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	253.65	15.47	9.28	9.28	12.37	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	234.16	0.00	0.00	0.00	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	250.02	12.92	8.40	12.27	9.04	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	262.42	16.10	6.44	6.44	19.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	334.55	0.00	0.00	23.90	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	238.76	17.93	5.70	13.04	14.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	188.49	12.17	6.72	13.43	11.33	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	258.70	14.37	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	229.05	19.29	4.02	16.88	10.45	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	223.43	21.24	8.31	9.23	11.08	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	286.53	30.16	0.00	30.16	30.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	207.22	10.38	3.30	10.86	3.78	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	223.12	10.88	3.63	9.98	7.26	0.00	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	162.17	14.74	0.00	29.48	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	260.42	13.99	4.30	11.84	10.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	331.59	29.22	5.08	15.25	13.98	0.00	2.54	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	213.59	0.00	16.43	16.43	49.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	254.43	13.39	9.57	14.67	7.65	0.64	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	269.75	10.94	7.29	7.29	14.58	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	221.26	15.80	0.00	15.80	31.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	294.19	17.85	10.00	17.14	15.71	0.00	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	295.33	13.27	6.64	6.64	19.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	271.03	0.00	0.00	20.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	194.76	13.27	5.56	14.20	11.11	0.31	0.62	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	303.79	15.80	1.76	5.27	12.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	298.60	15.72	3.14	15.72	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	275.37	9.04	11.13	20.17	9.74	0.00	2.09	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	190.33	19.92	0.00	0.00	2.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	181.55	16.21	9.73	12.97	9.73	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	181.36	7.85	4.36	9.59	6.98	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	182.23	4.50	2.25	6.75	6.75	0.00	0.00	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	174.23	6.97	3.48	3.48	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	139.75	16.00	6.40	11.73	10.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	162.10	13.85	5.54	15.24	11.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	313.46	8.55	2.85	2.85	5.70	0.00	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	188.69	7.36	1.84	9.20	11.97	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	169.42	9.08	6.05	0.00	6.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	192.47	0.00	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	164.95	2.11	2.11	8.46	3.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	260.87	32.31	13.95	9.55	4.81	0.41	0.57	0.00
Keratinocyte - epidermal, donor2	11349-117G8	257.68	30.45	14.06	9.37	5.27	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	315.20	37.39	16.85	13.54	7.00	0.09	0.95	0.09
Keratinocyte - oral, donor1	11251-116E9	278.57	26.79	14.42	7.49	6.13	0.34	0.57	1.02
Keratocytes, donor1	11527-119I6	465.55	36.45	11.69	18.91	8.25	0.69	0.69	0.34
Keratocytes, donor2	11607-120I5	684.33	64.45	21.09	16.41	11.72	0.00	2.34	0.00
Keratocytes, donor3	11688-122I5	324.85	21.14	6.32	7.31	5.73	0.40	0.40	2.77
Krukenberg tumor cell line:HSKTC	10687-109F3	525.30	17.58	6.59	6.59	2.20	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	159.65	24.81	7.55	7.55	3.24	1.08	0.00	1.08
Lens Epithelial Cells, donor2	11609-120I7	117.75	5.65	2.88	3.69	2.42	0.46	0.00	0.46
Lens Epithelial Cells, donor3	11690-122I7	87.69	9.08	2.62	4.94	2.93	0.00	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	145.49	12.81	5.69	6.76	3.56	0.00	0.71	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	139.26	15.35	4.74	7.81	4.19	0.28	0.00	2.23
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	127.98	9.44	3.94	4.88	3.62	0.16	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	155.94	8.60	4.30	4.84	4.84	0.00	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	168.93	14.50	5.99	8.19	3.15	0.00	0.00	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	137.57	10.46	4.85	5.28	3.56	0.11	0.11	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	134.61	13.54	7.80	6.57	4.51	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	190.37	18.46	6.57	9.61	4.05	0.00	1.77	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	143.42	11.40	5.77	6.33	4.22	0.00	0.70	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	153.86	11.87	5.54	5.54	3.16	0.00	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	151.04	12.80	7.17	6.79	4.85	0.00	0.78	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	170.89	17.40	6.30	8.52	6.30	0.00	0.37	1.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	151.56	14.63	3.48	5.57	4.88	0.00	1.05	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	151.94	13.83	6.20	8.11	3.10	0.24	0.48	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	154.38	13.05	7.00	7.69	5.22	0.14	0.82	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	132.73	12.32	3.70	8.31	4.31	0.31	0.62	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	151.82	10.91	5.92	7.79	3.43	0.00	0.00	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	163.23	13.54	4.76	7.14	2.93	0.00	0.37	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	156.00	10.86	4.28	8.56	1.97	0.00	0.00	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	162.25	15.23	5.27	6.15	3.81	0.00	0.29	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	189.43	18.17	7.47	9.21	4.73	0.50	0.75	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	167.80	8.24	4.36	6.30	5.82	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	171.54	18.04	6.46	5.92	3.77	0.27	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	161.07	16.95	4.84	7.87	5.45	0.15	0.45	1.06
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	157.60	7.26	4.15	4.67	4.15	0.00	0.00	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	170.23	13.40	5.03	8.17	4.40	0.00	0.21	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	159.09	12.93	4.66	8.27	4.06	0.00	0.15	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	166.47	13.07	4.82	6.19	3.44	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	154.28	14.86	6.77	7.15	5.08	0.00	0.56	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	144.62	12.83	5.94	8.16	4.14	0.21	0.64	1.59
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	157.97	16.48	6.78	4.36	3.88	0.48	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	172.34	17.53	7.28	2.98	3.97	0.00	0.66	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	152.14	14.50	6.44	8.55	4.21	0.12	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	134.76	12.59	7.03	6.29	3.33	0.00	0.00	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	162.58	12.35	3.71	3.95	3.95	0.00	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	156.61	14.57	6.60	7.56	4.26	0.00	1.10	1.24
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	139.91	12.87	4.50	6.11	3.22	0.64	0.64	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	171.03	14.00	8.52	7.00	2.74	0.30	0.61	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	152.14	14.70	5.18	6.44	4.34	0.00	0.56	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	151.11	12.80	3.20	4.27	3.91	0.00	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	225.91	20.36	7.27	5.82	3.39	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	153.43	15.41	5.91	8.25	3.27	0.16	0.93	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	151.84	16.83	6.09	6.80	6.09	0.36	1.07	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	183.92	20.58	8.49	8.17	5.55	0.33	1.31	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	165.50	12.24	6.36	7.06	3.53	0.00	0.71	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	154.94	11.88	4.70	4.83	2.60	0.00	0.87	1.11
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	194.14	13.32	7.94	6.92	3.84	0.00	0.26	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	103.83	11.04	5.07	5.07	2.39	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	154.09	9.06	0.00	2.27	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	211.73	10.74	5.37	1.53	2.30	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	187.78	9.65	2.97	1.48	4.45	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	214.95	13.12	3.81	3.39	2.54	0.00	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	208.89	11.25	2.11	5.63	2.11	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	157.84	8.41	1.87	1.87	1.87	0.00	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	179.83	11.34	3.09	2.58	3.61	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	220.05	10.71	3.57	3.57	3.57	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	168.51	10.63	5.20	4.98	4.07	0.68	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	181.19	14.25	4.65	1.16	3.78	0.87	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	203.03	9.45	4.95	3.15	2.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	189.82	14.09	4.06	3.79	4.47	1.08	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	216.71	20.03	4.11	3.08	3.59	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	211.36	12.70	5.65	2.47	4.94	0.00	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	163.24	10.66	2.00	4.66	2.67	0.67	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	192.55	12.73	4.08	1.02	3.06	1.02	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	202.51	11.74	4.00	2.67	3.47	0.27	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	208.78	11.90	3.78	3.40	4.35	0.38	0.94	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	219.66	19.63	2.45	4.29	4.91	1.23	2.45	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	229.95	13.86	3.26	4.89	6.52	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	198.66	10.00	3.96	4.37	3.54	0.62	1.04	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	214.40	13.17	5.61	4.76	5.32	0.56	2.24	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	214.31	6.18	6.18	3.09	6.18	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	218.89	9.29	4.64	4.64	2.90	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	188.33	9.57	4.48	3.29	2.99	0.30	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	196.41	12.72	6.64	1.11	6.09	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	225.17	11.31	3.18	7.07	2.47	0.35	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	219.79	9.22	4.06	2.21	5.90	0.37	2.21	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	247.52	18.42	4.61	2.30	4.61	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	235.62	15.35	3.84	4.61	6.14	0.38	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	224.75	14.72	5.10	2.83	5.10	1.13	3.40	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	195.27	10.67	4.92	1.64	1.64	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	244.47	10.85	5.87	6.33	4.07	0.90	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	278.64	13.64	2.15	3.59	2.15	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	234.53	9.71	1.49	5.23	4.48	0.75	4.48	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	265.69	13.01	5.20	5.20	4.83	1.11	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	250.26	9.48	5.17	3.02	4.31	0.86	0.86	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	248.33	12.84	3.43	0.00	9.42	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	266.54	12.99	6.00	4.33	3.66	0.33	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	272.09	17.50	3.02	3.62	4.22	0.60	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	286.53	15.64	3.55	3.55	6.40	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	258.13	13.06	5.84	4.12	3.09	0.34	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	285.01	17.71	5.37	2.15	3.22	0.54	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	282.14	10.10	4.04	4.04	2.69	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	272.25	11.85	5.19	4.44	4.82	0.74	1.85	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	181.42	12.79	2.33	0.00	1.16	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	263.38	14.81	4.23	5.29	4.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	284.11	12.80	3.60	3.20	5.60	0.80	1.20	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	200.62	10.90	3.63	3.63	3.63	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	240.69	14.56	2.30	1.53	3.83	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	216.55	15.78	1.48	5.43	4.93	0.00	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	212.65	15.05	3.76	5.65	4.70	0.94	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	218.73	10.56	4.53	4.02	3.02	1.51	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	207.74	14.42	4.96	3.60	3.60	0.90	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	211.70	12.05	1.72	5.16	10.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	202.63	10.24	5.34	3.56	3.12	1.34	2.23	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	214.67	12.90	4.69	3.52	3.52	0.78	1.17	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	230.25	15.83	5.28	1.98	1.32	0.00	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	245.45	12.45	5.71	6.23	4.15	0.52	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	230.16	11.38	3.06	2.19	3.94	0.44	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	216.93	16.77	6.71	1.68	1.68	0.56	1.12	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	251.29	12.81	3.09	3.97	3.09	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	244.54	10.03	5.01	5.40	2.70	0.00	1.54	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	245.58	14.68	4.56	1.52	4.56	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	256.65	10.57	5.29	1.44	5.29	0.48	1.92	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	254.43	13.12	5.17	3.58	6.36	0.40	1.99	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	250.34	12.76	4.86	7.90	6.08	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	241.40	13.83	4.84	3.46	2.77	1.38	0.69	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	244.33	12.92	3.42	4.18	2.28	0.76	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	265.95	14.46	4.13	3.61	3.61	1.03	1.03	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	266.05	13.30	6.65	3.63	5.44	0.00	1.21	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	260.81	11.73	5.70	3.17	4.12	0.00	1.58	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	263.88	17.06	3.20	4.80	3.20	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	237.34	16.09	3.45	3.45	6.90	1.15	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	264.83	16.97	3.60	6.17	4.11	0.51	2.06	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	275.87	14.85	4.24	4.95	2.83	0.00	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	265.58	22.70	2.84	4.54	5.11	1.13	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	254.61	14.14	3.74	4.16	6.24	0.42	1.66	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	317.91	12.53	4.70	2.35	7.83	2.35	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	265.14	13.78	9.19	2.51	5.85	0.42	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	264.38	11.62	3.72	2.79	4.18	0.46	2.79	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	278.99	15.39	4.68	2.01	8.03	0.00	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	321.32	17.64	4.81	2.67	3.74	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	301.86	11.31	4.45	4.85	3.64	2.02	2.02	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	346.00	12.85	0.92	3.67	6.42	0.00	2.75	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	364.53	22.23	5.33	8.00	4.45	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	327.67	16.53	5.13	3.99	4.56	0.00	1.14	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	365.81	21.47	9.20	3.83	4.60	0.77	1.53	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	316.82	18.60	5.47	2.19	6.02	0.00	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	331.41	12.92	7.13	4.45	3.56	0.45	1.34	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	335.60	17.42	6.50	5.46	5.46	0.52	1.04	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	435.00	19.89	7.96	4.64	7.29	1.33	4.64	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	552.91	20.79	6.24	4.16	2.08	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	120.80	7.52	2.05	3.65	4.10	0.00	0.23	0.68
Macrophage - monocyte derived, donor2	11313-117C8	92.12	18.90	3.49	4.04	2.57	0.00	0.55	0.00
Macrophage - monocyte derived, donor3	11389-118C3	124.26	11.80	4.72	4.72	4.46	0.00	0.39	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	190.11	19.65	7.97	6.90	1.06	0.00	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	152.75	19.49	5.07	3.49	2.69	0.32	0.48	0.32
Mallassez-derived cells, donor3	11930-125I4	168.04	24.60	7.51	8.76	4.45	0.00	0.83	0.00
Mammary Epithelial Cell, donor1	11273-116H4	283.49	49.52	20.93	16.64	9.27	0.10	1.00	0.10
Mammary Epithelial Cell, donor2	11350-117G9	358.75	48.35	20.85	13.32	5.79	0.29	0.58	0.00
Mammary Epithelial Cell, donor3	11422-118F9	581.66	53.63	19.95	20.70	10.73	0.75	2.00	0.50
Mast cell - stimulated, donor1	11487-119E2	214.23	3.39	2.71	3.39	4.07	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	302.79	8.00	4.33	7.79	6.16	1.84	0.22	0.11
Mast cell, donor2	11565-120D8	6670.67	140.27	106.69	50.82	85.59	24.96	8.32	0.00
Mast cell, donor3	11566-120D9	4459.27	111.44	79.69	49.08	67.99	47.73	4.95	0.00
Mast cell, donor4	11567-120E1	4418.75	82.44	58.86	36.17	49.82	20.03	3.19	0.35
Mast cell, expanded and stimulated, donor5	11940-126A5	192.84	8.21	2.11	3.55	3.44	2.66	0.55	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	865.02	33.85	16.34	16.93	12.26	1.75	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	314.45	6.88	2.87	7.00	6.31	4.36	1.26	0.11
Mast cell, expanded, donor8	11941-126A6	595.99	15.40	5.02	11.05	10.54	4.85	1.00	0.00
Melanocyte - dark, donor1	11502-119F8	126.76	7.96	2.79	4.18	3.78	0.20	0.30	0.70
Melanocyte - dark, donor2	11582-120F7	136.70	18.00	3.81	5.88	4.50	0.00	1.04	1.38
Melanocyte - dark, donor3	11663-122F7	267.74	12.68	5.43	8.26	5.14	0.00	0.80	0.36
Melanocyte - light, donor1	11274-116H5	332.86	18.34	7.05	6.58	7.29	0.24	0.47	0.47
Melanocyte - light, donor2	11351-117H1	542.56	20.47	6.82	8.19	12.28	0.00	2.05	0.68
Melanocyte - light, donor3	11423-118G1	398.92	24.28	11.27	12.14	9.54	0.00	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	522.60	14.79	9.79	10.83	6.25	0.52	1.25	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	536.00	29.85	7.53	11.83	9.68	0.27	1.88	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	328.39	10.45	4.82	8.84	7.50	0.27	1.34	0.54
Meningeal Cells, donor1	11493-119E8	355.93	36.60	15.88	15.38	11.41	0.37	0.12	0.25
Meningeal Cells, donor2	11573-120E7	165.50	9.24	4.84	4.40	3.52	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	274.58	26.57	11.82	13.28	7.58	0.16	0.73	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	354.73	32.51	15.97	21.10	8.84	0.86	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	96.20	17.51	6.84	6.24	2.62	0.20	0.10	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	579.55	52.57	17.08	13.14	13.14	0.00	1.31	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	711.64	81.11	34.01	28.78	18.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	368.85	41.62	17.94	21.53	8.61	1.44	2.87	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	197.16	15.88	5.72	6.35	4.66	0.00	0.42	1.06
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	308.62	27.14	5.53	11.56	6.53	1.01	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	457.75	55.60	21.10	20.22	12.75	0.22	1.32	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	459.54	47.49	28.49	20.46	10.23	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	520.71	64.04	24.35	20.46	14.12	0.00	1.84	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	275.08	28.81	10.11	6.51	5.96	0.55	0.83	1.94
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	268.38	14.87	5.58	8.18	4.83	0.00	0.37	1.86
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	120.65	12.10	3.42	5.13	2.37	0.26	0.26	1.18
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	152.52	17.21	5.34	6.23	4.15	0.00	0.30	0.89
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	135.46	4.67	0.00	7.01	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	348.38	39.70	18.57	14.09	13.45	0.00	0.00	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	279.66	54.58	24.81	22.33	8.15	0.71	1.06	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	144.48	8.44	3.75	5.00	3.44	0.31	0.31	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	267.05	29.03	7.98	11.61	8.71	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	153.01	24.66	8.75	9.81	5.30	0.27	0.27	1.06
Mesothelial Cells, donor2	12156-128G5	133.62	24.52	11.51	6.51	4.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	145.69	20.45	7.52	6.29	3.04	0.07	0.79	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	52.66	10.80	2.70	5.40	5.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	113.04	17.49	3.20	4.68	3.94	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	125.14	19.14	5.01	4.42	4.42	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	145.20	24.20	0.00	3.46	3.46	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	80.28	13.02	3.41	4.96	4.34	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	106.00	19.08	3.32	5.19	3.11	0.41	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	157.49	34.74	0.00	6.95	4.63	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	88.34	11.51	3.25	2.50	2.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	109.85	21.41	6.98	6.52	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	38.93	0.00	19.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	79.66	11.79	2.44	3.25	3.05	0.41	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	113.64	15.84	5.15	2.77	3.96	0.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	213.79	0.00	8.55	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	100.88	16.81	3.54	4.42	5.31	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	126.52	19.00	8.36	5.32	4.56	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	114.48	13.16	6.58	6.58	6.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	91.04	12.73	2.12	3.61	2.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	95.77	20.26	4.60	6.45	2.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	84.35	8.35	1.79	1.49	2.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	78.80	21.80	3.35	5.03	1.68	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	33.95	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	87.82	10.79	4.27	3.01	0.75	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	83.18	13.78	2.38	4.28	3.80	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	69.11	11.61	2.21	8.29	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	81.05	8.98	1.38	3.22	2.07	0.23	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	72.99	16.20	2.73	4.63	2.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	78.27	8.56	1.63	3.47	2.04	0.00	0.41	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	68.87	7.29	2.57	2.36	2.79	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	81.58	9.56	2.89	4.45	3.11	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	113.50	41.27	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	74.25	10.29	2.41	2.63	2.19	0.22	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	84.15	9.13	2.03	6.59	3.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	162.39	23.20	4.97	9.94	4.97	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	65.23	10.33	2.45	3.53	2.99	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	84.40	14.12	5.29	5.59	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	97.04	15.26	4.36	4.36	7.63	0.00	1.09	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	89.86	9.13	3.36	4.32	2.40	0.00	1.92	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	100.46	12.41	7.60	6.00	2.40	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	116.55	10.97	4.11	2.74	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	101.62	10.51	2.00	3.00	2.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	215.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	69.31	2.04	0.00	2.04	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	83.21	7.01	3.50	3.50	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	120.30	15.45	1.10	3.31	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	86.45	9.61	5.12	5.12	3.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	66.69	10.41	3.22	3.47	3.47	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	110.65	13.22	10.44	5.57	4.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	95.02	17.68	4.42	4.42	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	70.43	11.97	2.39	5.47	2.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	105.03	16.19	5.69	3.06	3.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	73.15	9.59	1.78	5.68	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	64.81	14.59	3.37	3.37	3.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	85.62	12.05	2.49	7.48	2.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	78.09	11.65	4.66	2.33	2.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	71.80	8.45	4.22	6.03	2.41	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	98.09	17.53	2.92	5.01	4.17	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	122.72	21.66	0.00	7.22	14.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	66.50	8.31	3.69	3.69	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	114.39	19.35	7.97	7.97	3.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	66.05	8.71	2.07	3.04	3.04	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	68.67	7.77	2.85	5.70	2.33	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	104.24	18.45	4.29	6.01	2.14	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	83.21	6.35	3.81	4.45	3.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	62.45	8.54	1.87	3.74	5.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	129.01	19.76	4.19	5.69	4.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	61.02	7.35	2.68	6.64	2.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	81.86	11.15	3.82	6.05	2.87	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	105.70	15.04	2.21	4.20	3.32	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	72.43	9.48	4.55	3.03	2.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	60.80	7.67	1.42	5.68	1.99	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	99.55	13.76	3.93	3.69	4.67	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	102.31	7.17	3.26	6.52	3.91	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	79.98	7.94	2.65	4.12	3.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	121.67	14.70	5.77	6.05	2.88	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	73.77	4.53	2.47	5.77	0.41	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	85.17	9.53	1.49	3.28	2.98	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	97.94	11.30	0.00	3.77	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	60.60	1.78	1.78	7.13	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	95.61	4.60	2.30	2.63	2.30	0.33	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	151.48	6.31	1.05	1.05	3.16	0.00	2.10	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	97.46	3.95	3.76	1.98	2.97	0.00	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	108.03	10.24	3.73	4.66	3.73	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	92.38	4.51	3.00	4.13	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	128.64	15.45	2.40	7.72	2.40	0.00	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	124.18	4.07	2.38	2.38	1.81	0.34	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	139.98	3.68	0.74	2.21	3.68	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	109.56	1.83	0.73	3.30	2.20	0.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	172.67	15.56	0.00	0.00	1.56	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	66.27	4.81	1.07	1.60	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	112.05	3.86	3.86	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	158.56	5.05	1.01	6.06	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	86.01	2.95	3.37	1.69	1.69	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	49.03	0.00	0.00	2.72	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	9.54	1.91	0.64	0.64	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	0.81	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	36.25	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	542.47	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	349.08	3.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	166.34	23.76	0.00	9.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	326.28	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	344.70	34.25	10.34	13.14	8.83	0.22	0.65	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	331.34	18.81	7.32	15.16	10.97	0.52	1.57	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	588.72	49.39	30.04	20.02	13.35	2.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	677.81	68.45	23.79	22.96	9.60	1.25	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	508.63	41.26	9.32	10.65	10.46	2.09	0.57	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	687.81	47.88	20.75	33.51	11.17	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	560.95	42.84	25.84	14.96	13.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	170.90	9.19	9.19	3.68	3.68	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	565.02	43.53	23.86	17.58	10.88	0.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	747.99	64.39	18.83	19.06	11.85	1.86	0.23	0.46
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	624.49	43.51	21.89	17.02	7.57	1.35	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	580.04	39.52	14.09	16.61	9.67	0.84	0.21	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	244.96	33.40	11.13	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	856.21	34.25	25.81	17.87	12.41	1.99	1.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	328.86	28.69	5.95	8.66	4.87	1.08	0.81	1.62
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	595.95	45.11	21.53	19.04	10.20	0.91	0.45	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	743.35	48.99	14.86	18.94	10.78	0.98	0.65	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	348.84	27.16	9.84	8.02	5.10	1.46	0.36	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	489.06	40.31	10.61	19.10	12.73	1.59	1.59	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	715.56	39.02	23.41	17.41	10.21	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	202.49	17.07	3.61	2.30	2.95	1.31	0.00	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	575.04	53.34	18.54	17.40	9.11	2.28	0.33	0.81
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	358.76	25.05	11.11	11.29	6.53	1.76	0.53	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	560.48	57.66	22.50	14.06	16.17	0.70	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	687.72	37.70	9.65	9.65	13.33	0.46	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	455.02	37.60	17.03	12.85	8.03	1.93	0.32	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	213.83	20.35	6.55	3.79	8.97	2.07	0.34	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	123.89	10.11	0.00	0.00	2.53	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	330.39	28.29	12.48	11.58	7.13	0.45	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	441.60	44.03	16.51	11.43	13.13	0.42	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	523.60	29.43	7.83	6.41	12.34	0.47	0.24	1.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	451.14	39.92	19.75	17.60	7.73	2.58	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	126.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	515.49	44.98	10.00	16.33	4.67	0.67	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	293.96	30.66	5.41	9.92	4.51	0.90	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	318.63	38.09	13.89	13.09	11.90	1.19	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	618.48	42.72	15.79	13.93	8.36	1.86	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	334.86	32.54	4.16	7.95	7.95	3.41	0.76	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	297.21	34.54	8.80	10.10	6.52	0.33	0.98	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	483.72	47.06	12.64	16.56	6.97	0.44	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	259.16	28.04	12.21	5.43	5.43	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	281.33	33.51	10.58	16.76	7.94	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	620.97	31.91	12.63	14.63	7.98	0.00	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	645.85	50.60	12.40	10.42	5.46	0.99	1.49	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	338.80	29.86	14.55	12.25	7.27	0.77	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	581.91	39.62	11.49	15.73	14.21	1.21	1.81	1.21
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	220.14	24.09	5.53	8.84	5.08	1.11	0.66	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	330.02	39.98	14.91	11.52	6.78	2.71	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	235.04	5.11	10.22	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	624.92	41.46	7.32	14.02	10.36	2.44	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	295.22	33.05	5.67	6.61	6.29	0.00	0.00	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	498.77	37.23	11.50	10.29	7.87	3.03	0.00	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	299.84	22.15	17.41	5.54	3.96	3.96	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	102.03	18.14	2.27	4.53	3.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	156.79	30.35	5.06	0.00	5.06	0.00	5.06	5.06
Myoblast, donor1	11241-116D8	221.87	34.41	15.53	10.81	5.59	0.12	1.37	0.00
Myoblast, donor2	11322-117D8	376.86	42.39	13.81	15.15	10.16	0.77	2.69	0.58
Myoblast, donor3	11398-118D3	274.11	31.45	10.43	12.28	5.21	0.17	0.84	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	54.87	0.88	0.15	1.17	0.73	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	151.30	28.29	16.91	11.07	8.92	4.92	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	301.56	34.98	25.63	18.09	19.00	9.95	1.51	0.00
Natural Killer Cells, donor3	11387-118C1	230.80	32.03	15.64	12.15	15.09	6.81	0.18	0.18
Neural stem cells, donor1	11275-116H6	166.95	11.25	7.98	5.44	3.27	0.36	0.00	0.36
Neural stem cells, donor2	11352-117H2	90.51	5.78	5.78	1.93	3.85	0.00	0.00	1.93
Neurons, donor1	11494-119E9	256.03	11.38	4.55	6.83	4.55	0.00	0.00	3.41
Neurons, donor2	11574-120E8	44.69	2.86	1.54	1.76	1.32	0.88	0.00	2.20
Neurons, donor3	11655-122E8	148.81	9.04	2.47	4.93	8.22	0.82	0.82	1.64
Neutrophils, donor1	11233-116C9	3.71	0.00	0.00	0.00	0.93	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	0.00	0.00	2.90	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	7.94	0.00	0.00	1.22	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	274.04	18.40	6.06	7.96	7.24	0.00	0.47	2.37
Nucleus Pulposus Cell, donor2	11409-118E5	365.65	21.16	6.51	8.79	10.42	0.33	1.95	2.93
Nucleus Pulposus Cell, donor3	11462-119B4	353.57	26.87	10.23	13.44	6.62	0.00	1.00	1.40
Olfactory epithelial cells, donor1	11933-125I7	306.96	23.40	11.15	10.32	8.12	4.13	1.51	0.28
Olfactory epithelial cells, donor2	11934-125I8	451.46	33.44	12.16	13.17	9.12	0.72	3.62	0.72
Olfactory epithelial cells, donor3	11935-125I9	344.37	24.97	8.63	9.99	8.51	1.25	1.36	0.23
Olfactory epithelial cells, donor4	11936-126A1	393.78	27.76	13.25	8.96	7.50	1.07	0.68	1.17
Oligodendrocyte - precursors, donor1	11496-119F2	164.30	16.25	7.22	2.41	8.43	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	473.24	48.71	17.44	10.85	8.51	0.00	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	208.05	29.72	13.72	5.72	10.29	0.00	3.43	1.14
Osteoblast - differentiated, donor3	11425-118G3	236.49	24.21	5.59	4.97	4.97	0.62	0.00	1.24
Osteoblast, donor1	11277-116H8	536.08	68.79	22.87	20.13	15.24	1.95	1.56	1.76
Osteoblast, donor2	11354-117H4	405.24	37.22	14.05	16.86	9.13	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	548.83	51.36	20.79	22.39	9.60	0.53	2.31	0.18
Pancreatic stromal cells, donor1	11249-116E7	519.14	46.33	14.07	14.83	7.24	0.84	1.68	0.84
Pericytes, donor1	11491-119E6	250.79	21.81	7.23	9.57	6.90	0.00	0.67	1.00
Pericytes, donor2	11571-120E5	390.93	31.01	12.45	16.52	16.75	0.23	0.68	0.91
Pericytes, donor3	11652-122E5	281.17	35.40	16.07	12.21	8.95	0.00	0.20	0.20
Perineurial Cells, donor1	11499-119F5	268.09	24.98	10.28	10.51	6.89	0.23	0.68	1.02
Perineurial Cells, donor2	11579-120F4	115.20	11.87	3.04	5.06	3.59	0.09	0.18	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	21.67	3.19	2.23	1.27	2.87	1.91	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	46.52	7.10	3.92	5.88	4.90	7.59	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	30.93	3.24	1.42	2.98	3.11	1.68	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	577.83	27.26	14.11	12.20	4.54	1.20	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	389.22	29.94	11.09	7.76	12.20	1.11	2.22	1.11
Placental Epithelial Cells, donor3	11427-118G5	415.62	21.20	8.64	10.60	6.87	1.57	0.79	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	175.63	13.61	3.48	4.75	4.11	0.00	1.58	0.32
Preadipocyte - breast, donor1	11467-119B9	231.86	25.32	8.07	9.00	6.75	0.19	2.06	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	539.99	47.12	18.27	22.06	10.44	1.04	0.65	0.39
Preadipocyte - breast, donor2	11328-117E5	320.39	29.04	10.36	10.13	5.40	0.00	2.03	0.90
Preadipocyte - omental, donor1	11468-119C1	199.16	26.43	11.30	6.50	4.58	0.32	0.75	0.43
Preadipocyte - omental, donor2	11329-117E6	203.83	24.01	6.11	4.36	1.75	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	233.50	23.35	8.88	11.75	5.44	0.43	0.72	0.86
Preadipocyte - perirenal, donor1	11469-119C2	258.86	27.56	10.83	5.91	8.86	0.00	4.92	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	437.34	62.65	22.11	19.35	5.84	0.00	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	381.78	39.13	16.11	15.76	8.85	0.35	1.24	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	474.92	44.27	19.24	18.05	9.37	0.17	2.04	0.51
Preadipocyte - visceral, donor1	11280-116I2	459.78	50.21	20.68	14.16	10.71	0.37	1.21	0.09
Preadipocyte - visceral, donor2	11357-117H7	338.23	24.39	6.90	11.96	5.06	0.92	1.84	0.46
Preadipocyte - visceral, donor3	11429-118G7	617.23	56.84	27.38	19.54	11.18	1.57	4.60	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	46.01	0.60	0.15	0.30	0.60	0.00	0.00	0.30
Prostate Epithelial Cells, donor2	11331-117E8	147.60	16.79	8.53	7.18	3.39	0.41	0.54	0.41
Prostate Epithelial Cells, donor3	11404-118D9	94.86	13.41	6.00	3.49	2.02	0.06	0.31	0.18
Prostate Stromal Cells, donor1	11254-116F3	260.15	29.50	10.59	12.07	6.49	0.34	1.37	0.34
Prostate Stromal Cells, donor2	11332-117E9	343.89	36.94	17.21	12.19	10.04	0.54	1.79	0.18
Prostate Stromal Cells, donor3	11405-118E1	295.62	24.61	7.92	11.89	7.30	0.21	1.67	0.52
Renal Cortical Epithelial Cells, donor1	11516-119H4	178.84	18.98	9.85	12.04	5.84	0.00	0.36	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	113.67	10.88	4.44	3.95	1.94	0.14	0.42	0.42
Renal Epithelial Cells, donor1	11517-119H5	305.35	32.46	9.64	18.77	10.65	0.00	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	239.00	31.30	10.67	12.09	8.54	0.71	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	81.41	8.15	3.71	4.87	2.33	0.11	0.11	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	387.40	21.79	11.57	9.53	8.17	0.68	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	344.32	32.07	15.90	12.80	12.13	0.00	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	286.84	22.20	8.44	8.44	8.44	0.44	0.67	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	183.00	11.98	6.65	4.66	2.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	279.73	25.53	10.34	11.22	5.94	0.22	0.66	0.66
Renal Mesangial Cells, donor2	11598-120H5	243.90	25.71	6.90	9.40	8.15	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	187.25	16.37	5.27	9.43	5.27	0.00	1.39	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	249.63	27.65	14.76	13.15	5.91	0.00	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	236.99	25.30	6.33	10.12	6.33	0.00	1.27	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	244.14	23.91	10.22	12.34	5.98	0.39	0.39	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	177.09	17.63	8.56	9.33	7.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	100.05	9.66	2.56	5.12	3.70	0.28	0.28	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	174.95	22.64	7.20	6.17	8.23	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	92.84	9.28	5.52	3.26	2.26	0.25	0.50	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	120.67	2.67	2.67	2.14	1.34	0.27	0.00	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	294.82	8.93	4.47	4.47	1.79	2.68	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	157.96	5.50	2.75	4.95	7.71	1.10	0.00	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	211.72	8.70	4.06	5.80	5.22	1.16	1.16	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	253.03	10.14	6.63	5.72	5.72	0.65	0.91	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	334.16	15.49	8.94	9.63	9.33	0.10	0.60	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	397.41	18.29	10.15	14.50	9.26	1.00	1.23	2.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	346.95	16.13	7.69	8.68	6.82	1.61	0.62	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	344.39	14.22	13.17	9.56	7.93	0.82	1.40	1.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	450.01	17.10	8.55	10.86	8.55	1.16	0.23	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	353.77	13.69	6.71	10.13	5.75	0.68	0.68	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	338.55	11.50	7.41	9.53	8.62	1.51	1.36	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	408.02	19.17	13.26	12.90	8.24	1.43	0.72	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	396.51	15.06	7.03	7.32	9.90	1.43	0.29	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	347.27	13.95	7.51	8.59	9.01	1.72	1.07	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	431.03	17.26	11.51	12.39	11.95	1.77	1.11	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	386.75	16.25	4.59	6.88	6.88	1.34	0.38	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	325.23	12.39	7.92	10.06	7.17	2.79	0.65	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	341.05	15.41	6.58	8.08	8.08	1.50	0.19	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	407.94	18.05	6.64	9.55	7.83	0.80	0.27	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	289.88	15.87	7.88	10.12	8.18	2.43	0.78	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	405.21	17.19	10.50	9.93	7.83	2.29	1.34	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	384.56	17.83	6.51	7.48	8.44	0.64	0.32	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	352.34	10.37	5.33	7.29	7.57	2.52	0.84	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	402.81	18.80	8.03	13.84	10.08	1.71	0.34	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	434.49	20.24	6.93	7.84	9.66	0.73	0.00	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	310.87	13.37	7.48	9.93	6.01	1.23	0.86	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	441.11	18.00	10.61	15.58	11.15	3.22	0.94	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	487.08	19.81	7.55	8.96	12.03	0.00	0.47	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	323.02	15.67	6.55	10.52	7.74	3.37	0.20	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	499.03	23.38	10.52	15.20	8.65	1.17	1.40	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	428.60	17.00	6.84	8.50	8.09	0.21	1.04	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	414.55	19.25	7.30	13.72	11.72	2.43	1.99	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	378.50	19.01	9.19	13.37	9.61	1.88	0.21	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	403.62	18.98	9.15	7.94	11.44	0.54	0.13	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	364.43	18.05	9.37	11.75	8.34	1.70	0.68	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	393.11	19.09	8.68	9.06	9.45	0.77	0.00	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	405.60	22.35	9.46	8.25	10.66	0.86	0.69	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	346.76	17.28	8.50	11.93	9.19	0.82	0.69	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	420.11	21.51	9.85	13.46	11.82	1.81	0.99	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	382.11	18.58	5.28	8.52	8.86	0.17	0.51	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	352.88	17.31	9.03	10.21	10.95	1.04	0.44	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	428.35	9.60	9.86	8.53	9.06	1.07	0.27	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	246.94	5.95	3.59	6.08	5.39	0.00	0.41	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	315.96	10.71	6.67	8.57	7.86	0.95	0.48	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	396.63	8.06	4.84	8.67	5.84	0.00	0.81	3.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	355.88	7.35	4.43	5.09	6.69	0.75	1.22	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	390.59	6.99	3.84	11.88	8.04	0.00	0.70	3.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	287.10	5.44	3.63	4.84	7.25	1.51	0.30	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	420.15	12.36	5.26	5.75	6.98	0.73	0.73	3.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	376.11	10.63	5.82	8.44	5.97	3.35	0.29	4.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	566.45	10.95	6.08	13.39	15.21	1.22	0.61	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	462.65	12.96	4.52	6.33	5.73	0.30	1.21	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	510.96	17.64	6.79	9.95	11.76	1.13	1.13	3.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	583.20	10.48	5.69	11.98	11.38	1.20	0.60	6.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	277.71	7.20	3.66	3.54	5.43	0.24	0.71	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	392.53	12.38	6.19	11.31	5.98	1.49	4.91	4.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	423.09	10.82	9.62	6.01	9.01	1.80	2.40	4.81
Schwann Cells, donor1	11498-119F4	496.88	43.26	18.62	20.69	18.43	0.00	2.26	0.75
Schwann Cells, donor2	11578-120F3	377.67	44.23	3.40	17.01	13.61	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	485.26	33.08	12.27	16.21	14.46	0.22	0.88	1.10
Sebocyte, donor1	11220-116B5	117.77	14.79	6.03	6.57	7.12	0.00	0.00	0.55
Sebocyte, donor2	11301-117B5	155.79	17.00	9.19	6.43	4.60	0.00	0.46	0.92
Sebocyte, donor3	11378-118B1	306.28	17.31	9.89	8.66	6.18	0.21	0.82	0.41
Sertoli Cells, donor1	11255-116F4	258.43	28.16	13.25	11.60	11.60	0.00	3.31	6.63
Sertoli Cells, donor2	11333-117F1	460.37	56.49	8.47	8.47	8.47	0.00	11.30	0.00
Skeletal Muscle Cells, donor1	11281-116I3	307.31	27.01	11.35	10.47	7.83	0.09	0.70	2.20
Skeletal Muscle Cells, donor2	11358-117H8	237.82	20.96	10.12	13.01	10.84	1.45	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	1256.57	89.46	44.31	53.51	15.88	2.51	6.69	1.67
Skeletal Muscle Cells, donor4	11451-119A2	329.43	35.97	16.49	14.30	9.27	0.16	1.41	0.47
Skeletal Muscle Cells, donor5	11455-119A6	282.42	32.40	13.97	12.49	8.03	0.00	1.49	0.59
Skeletal Muscle Cells, donor6	11459-119B1	338.43	36.63	17.08	17.24	11.23	0.77	2.15	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	200.60	21.67	7.81	11.34	7.94	0.13	0.63	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	321.33	32.25	13.56	13.70	12.41	0.29	2.14	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	335.43	32.44	13.79	17.56	8.93	0.20	0.69	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	278.37	26.46	11.80	10.11	7.50	0.42	0.59	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	919.90	82.51	30.40	36.19	23.88	2.17	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	814.45	61.64	27.38	20.92	15.69	0.41	5.64	1.51
Skin - palm, donor1	10286-104F7	738.68	102.07	32.23	24.17	21.49	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	172.84	12.54	5.48	3.75	3.60	0.00	0.72	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	225.74	13.90	1.64	1.64	1.64	1.64	0.82	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	242.52	11.29	5.45	5.06	4.15	0.13	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	114.68	18.91	5.70	3.75	2.64	0.00	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	136.44	11.53	4.22	6.61	2.39	0.00	0.28	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	256.70	17.97	10.15	5.71	5.29	1.06	0.21	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	117.30	7.94	3.15	3.82	1.57	0.00	0.30	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	235.14	45.05	12.03	12.96	4.94	0.31	0.93	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	411.98	52.69	15.56	14.01	11.12	1.11	0.67	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	288.04	43.50	15.87	18.22	6.47	0.59	0.00	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	215.47	32.71	14.14	27.62	6.63	0.22	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	370.94	58.28	17.72	16.54	8.66	1.18	1.18	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	326.02	50.22	8.50	13.91	6.18	0.77	0.00	2.32
Smooth Muscle Cells - Bladder, donor1	11519-119H7	166.13	6.00	0.00	2.00	0.00	0.00	0.00	3.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	264.16	31.81	13.71	11.84	5.46	0.93	0.13	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	429.79	38.57	14.63	15.07	7.09	0.44	1.33	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	217.01	35.85	12.03	12.55	5.63	0.90	1.02	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	202.19	16.28	7.16	10.42	9.44	0.00	0.98	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	173.95	18.31	4.73	10.63	4.43	0.00	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	136.81	21.21	7.40	10.39	4.84	0.28	0.71	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	488.84	54.33	19.68	18.71	9.92	0.00	0.81	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	406.72	35.62	6.09	10.66	12.48	0.00	1.22	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	470.78	60.36	20.96	22.98	8.33	1.01	1.52	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	171.38	36.72	18.36	6.12	12.24	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	343.32	39.10	13.83	17.64	7.63	0.95	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	189.50	15.34	7.52	6.78	2.51	0.15	0.44	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	213.09	18.94	6.67	7.75	5.81	0.22	0.22	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	212.75	19.52	6.82	8.61	5.67	0.10	0.63	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	337.20	54.76	19.33	23.05	7.73	0.93	0.31	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	360.01	63.59	21.56	34.49	5.39	0.00	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	200.53	35.86	12.85	11.36	5.08	0.00	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	336.62	39.94	10.92	17.07	9.56	0.00	0.00	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	152.66	13.98	4.71	3.38	3.69	0.55	0.47	1.65
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	417.36	36.73	18.62	12.78	5.94	0.60	1.01	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	162.02	23.89	8.65	12.74	3.87	0.00	0.68	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	414.82	54.95	16.91	12.08	8.45	1.21	4.23	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	183.86	23.84	7.95	6.62	5.83	0.79	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	255.93	31.16	10.12	8.26	7.59	0.40	0.53	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	260.96	19.03	7.26	10.39	6.76	0.38	1.63	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	323.67	35.51	11.67	10.15	5.83	0.51	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	608.67	68.90	30.46	23.97	9.35	0.45	0.75	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	621.89	54.76	21.75	15.75	7.50	1.50	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	426.43	175.74	46.52	197.71	24.55	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	419.49	53.95	17.67	23.72	7.44	0.93	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	284.75	28.27	11.11	11.61	5.55	0.50	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	313.71	47.32	21.62	14.73	7.21	0.31	1.57	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	331.58	44.84	17.70	12.39	10.03	0.00	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	313.48	45.40	19.66	17.33	7.83	0.17	0.42	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	393.35	45.78	9.34	7.47	8.88	0.47	0.47	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	295.61	45.77	17.85	19.14	6.62	0.43	1.01	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	487.48	43.60	20.14	21.42	10.71	1.53	1.53	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	390.92	36.85	18.62	20.87	8.27	2.07	1.13	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	243.29	24.73	8.11	9.36	5.03	0.42	0.42	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	251.95	18.01	7.29	8.80	4.61	0.34	0.42	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	140.95	16.67	5.24	5.71	3.33	1.43	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	292.62	40.86	19.33	15.17	8.56	0.49	0.49	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	229.12	33.14	7.29	10.16	6.85	0.00	0.22	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	485.10	65.54	28.67	22.24	7.31	1.17	1.76	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	253.45	17.10	5.64	3.30	5.83	0.19	0.00	2.14
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	238.80	33.85	9.78	8.99	6.88	0.79	1.06	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	195.64	20.46	6.70	6.32	5.95	0.00	1.86	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	240.40	34.86	12.22	6.83	8.62	0.00	1.44	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	288.16	49.11	20.16	12.49	7.38	0.57	2.56	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	418.68	44.90	18.12	13.79	9.85	0.79	1.18	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	188.69	20.32	6.60	8.13	4.32	0.76	0.76	2.29
Smooth muscle cells - airway, control, donor2	11967-126D5	272.74	26.75	9.18	10.78	5.19	0.80	0.80	3.19
Smooth muscle cells - airway, control, donor3	11968-126D6	321.03	33.44	6.69	11.70	8.78	0.00	0.84	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	312.14	29.34	5.50	11.92	6.42	0.00	2.75	0.92
Synoviocyte, donor1	11291-117A4	463.72	45.45	15.82	12.96	6.40	2.36	2.86	0.17
Synoviocyte, donor2	11368-117I9	617.02	39.73	11.90	11.90	9.55	0.34	2.35	1.01
Synoviocyte, donor3	11440-118H9	481.00	24.58	9.16	7.15	5.81	0.22	0.89	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	618.90	46.10	12.15	17.87	10.36	0.00	0.71	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	336.95	27.75	9.91	17.84	17.84	0.00	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	443.88	33.34	13.66	16.44	9.26	0.23	2.08	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	180.07	30.32	12.40	10.54	5.23	0.14	0.14	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	257.06	25.13	12.76	11.60	5.03	0.00	0.39	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	206.73	37.22	9.74	17.75	4.01	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	123.76	3.20	1.72	1.85	1.35	0.12	0.37	0.86
Urethra, donor2	10319-105A4	422.63	5.40	5.40	3.60	8.99	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	166.04	27.36	11.16	6.91	3.45	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	198.68	30.04	9.61	10.01	3.61	0.40	1.20	0.00
Urothelial Cells, donor3	11681-122H7	246.17	31.63	13.29	11.00	5.27	0.00	0.69	0.23
Urothelial cells, donor0	11216-116B1	146.22	19.61	10.03	5.35	2.67	0.22	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	48.05	0.89	0.89	2.67	0.89	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	81.49	1.43	0.00	2.86	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	38.33	1.37	0.00	4.79	6.85	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	19.63	1.03	0.34	2.75	0.69	0.34	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	21.50	1.16	0.00	0.58	1.74	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	38.53	3.12	0.00	3.12	2.08	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	41.30	0.92	3.67	2.75	4.59	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	48.38	2.74	0.00	6.39	2.74	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	92.27	8.51	3.58	4.19	2.84	0.12	0.25	0.49
Wilms' tumor cell line:HFWT	10597-108E3	295.69	26.40	5.28	14.08	11.44	0.00	0.00	4.40
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	222.06	19.55	6.98	5.87	3.35	0.84	0.84	0.00
achilles tendon, donor2	10292-104G4	417.44	24.80	6.20	10.33	14.47	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	3.57	0.25	0.00	0.00	0.25	0.00	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	2.99	0.00	0.00	0.27	0.00	0.00	0.00	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1.41	0.00	0.00	0.00	0.00	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	11.63	0.21	0.00	0.42	0.21	0.21	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	65.33	1.36	1.09	0.27	1.63	0.27	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	8.37	0.88	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	5.44	0.00	0.00	0.00	0.39	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	46.55	2.76	0.92	1.47	2.39	0.00	0.18	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	42.91	3.90	3.90	0.00	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	23.94	0.93	0.46	0.46	1.39	0.00	0.00	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	21.75	1.04	0.00	0.78	1.55	1.55	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	8.18	0.29	0.00	0.00	0.88	0.00	0.00	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	93.42	2.79	1.86	1.86	2.32	0.93	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	11.52	0.00	0.00	0.00	0.00	0.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	303.27	6.75	2.76	5.22	5.22	0.00	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	102.41	3.84	2.13	2.99	1.71	0.85	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	139.52	3.94	2.73	0.61	2.12	0.91	0.30	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	110.97	2.65	2.17	1.93	2.65	3.13	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	59.92	4.23	0.67	2.00	2.23	0.22	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	121.74	5.00	3.00	5.00	3.34	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	26.01	1.86	0.00	1.86	0.00	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	182.68	5.27	1.13	10.55	11.30	0.38	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	21.37	0.00	0.00	0.87	0.87	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	1.87	0.00	3.75	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	227.73	20.02	7.54	5.65	3.77	0.24	0.24	0.00
adipose tissue, adult, pool1	10010-101C1	225.54	11.01	3.10	2.17	2.17	0.16	0.16	0.78
adipose, donor1	10184-103D4	4.10	0.00	0.00	0.00	0.59	0.00	0.00	4.10
adipose, donor2	10185-103D5	24.33	0.00	0.00	0.81	0.41	0.41	0.00	1.22
adipose, donor3	10186-103D6	30.50	2.18	1.36	2.18	2.45	0.00	0.27	1.09
adipose, donor4	10187-103D7	27.74	5.20	0.87	2.60	18.20	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	41.51	4.42	1.10	2.53	2.05	0.00	0.00	1.58
adrenal gland, adult, pool1	10081-102A9	178.25	21.83	18.19	3.64	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	44.42	0.53	0.27	1.07	1.47	0.13	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	302.28	25.73	7.15	12.51	6.07	3.57	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	580.32	30.60	11.13	4.64	4.87	1.16	1.85	0.70
amniotic membrane cells, donor2	12236-129G4	371.24	10.82	5.07	6.42	6.42	1.69	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	556.21	24.45	10.02	5.60	4.42	2.06	1.18	0.00
amygdala - adult, donor10196	10167-103B5	28.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	33.05	0.81	0.00	0.00	0.20	0.00	0.00	2.03
amygdala, newborn, donor10223	10360-105E9	62.94	2.58	1.61	1.94	3.23	2.26	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	98.68	3.69	1.66	1.27	0.76	0.00	0.13	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	107.88	10.37	5.52	5.29	1.76	0.44	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	164.35	6.35	0.67	3.01	1.67	0.00	0.00	1.34
aorta, adult, pool1	10052-101G7	375.99	18.44	8.43	6.28	6.67	3.14	0.98	0.98
appendix, adult	10189-103D9	262.37	7.76	2.33	2.33	3.10	0.78	0.78	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	29.58	0.69	0.69	1.38	0.69	0.00	0.34	1.03
artery, adult	10190-103E1	245.92	9.51	4.08	4.08	1.36	2.72	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	365.79	17.38	7.68	11.30	8.11	3.77	0.58	2.61
b cell line:RPMI1788	10427-106D4	89.96	3.72	1.93	2.53	3.27	0.30	0.00	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	315.18	35.24	12.49	12.49	6.66	1.94	1.39	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	206.90	24.71	11.11	7.14	3.47	0.50	0.20	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	93.56	4.02	1.51	2.01	1.00	0.33	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	120.80	3.91	2.80	2.24	3.91	2.80	0.00	1.68
bladder, adult, pool1	10011-101C2	164.81	7.39	2.06	2.50	1.85	0.11	0.33	0.98
blood, adult, pool1	10053-101G8	39.86	0.00	0.00	8.86	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	414.47	35.97	15.41	16.27	7.71	1.71	0.86	0.86
bone marrow, adult	10192-103E3	193.00	15.52	5.40	6.75	6.75	0.00	0.00	0.67
brain, adult, donor1	10084-102B3	62.53	4.10	0.00	0.00	2.05	0.00	0.00	2.05
brain, adult, pool1	10012-101C3	43.21	1.45	0.33	1.67	0.67	0.11	0.22	1.22
brain, fetal, pool1	10085-102B4	16.03	0.00	0.00	5.34	0.00	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	180.71	13.54	5.29	8.59	4.29	0.66	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	153.53	5.74	2.62	2.87	2.75	0.00	0.00	0.12
breast, adult, donor1	10080-102A8	264.54	7.58	1.26	3.79	1.89	0.00	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	275.55	16.39	12.58	5.46	6.61	0.51	0.25	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	451.77	21.65	11.75	11.13	13.61	8.04	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	148.95	8.75	2.76	5.30	4.37	0.69	0.92	1.15
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	211.34	17.19	7.75	4.84	5.08	0.48	0.97	0.00
carcinoid cell line:NCI-H1770	10703-109H1	86.98	3.29	0.00	3.29	1.88	0.00	0.00	1.88
carcinoid cell line:NCI-H727	10735-110B6	89.04	5.03	3.50	2.84	2.08	0.98	0.00	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	66.87	2.22	0.00	2.85	1.90	0.00	0.00	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	71.60	2.93	1.60	1.06	2.13	0.00	0.53	1.33
caudate nucleus - adult, donor10196	10177-103C6	56.41	1.15	0.00	1.15	1.15	0.00	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	38.65	0.50	0.17	0.00	0.33	0.00	0.17	2.51
caudate nucleus, adult, donor10258	10379-105H1	28.27	0.00	0.00	0.76	0.76	0.00	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	66.29	2.20	0.00	0.73	0.37	1.10	0.00	1.10
cerebellum - adult, donor10196	10173-103C2	17.48	0.00	2.91	0.00	0.00	0.00	0.00	8.74
cerebellum, adult, donor10252	10166-103B4	32.67	1.07	0.85	0.21	0.64	0.00	0.00	16.87
cerebellum, adult, pool1	10083-102B2	23.11	1.72	0.69	1.38	0.69	0.00	0.00	6.21
cerebellum, newborn, donor10223	10357-105E6	49.82	0.00	0.00	0.00	0.00	0.00	0.00	18.27
cerebral meninges, adult	10188-103D8	63.03	2.52	0.50	2.52	0.50	0.00	0.50	1.76
cerebrospinal fluid, donor2	10294-104G6	149.83	2.92	2.19	0.73	5.12	0.00	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	158.30	9.78	3.16	4.74	2.73	0.00	0.00	0.58
cervical cancer cell line:ME-180	10553-107I4	227.53	20.88	5.47	4.81	2.82	0.66	0.17	0.17
cervix, adult, pool1	10013-101C4	294.08	9.66	5.35	3.99	3.57	2.20	0.42	1.78
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	123.73	13.66	7.25	6.69	3.62	0.42	0.84	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	118.87	20.90	5.23	10.45	1.31	2.61	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	122.29	5.22	2.36	2.86	2.11	0.00	0.25	0.75
choriocarcinoma cell line:SCH	10785-110H2	259.24	6.90	2.46	4.68	4.19	0.00	0.62	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	116.69	1.90	0.24	1.19	1.42	0.00	0.24	0.71
chorionic membrane cells, donor1	12238-129G6	375.52	13.11	7.12	5.41	0.85	1.71	1.99	0.28
chorionic membrane cells, donor2	12239-129G7	254.94	15.11	7.16	6.36	4.37	0.70	0.80	0.30
chorionic membrane cells, donor3	12240-129G8	320.90	7.14	3.85	4.40	2.75	3.30	2.75	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	10.57	0.00	0.00	0.38	0.19	1.34	0.00	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	139.59	5.49	2.96	4.22	5.07	0.00	0.00	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	129.68	4.62	2.31	2.57	4.88	0.00	0.51	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	145.61	5.32	3.39	4.84	5.08	0.00	0.00	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	120.54	5.29	1.83	5.90	4.28	0.00	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	75.97	5.89	2.06	5.30	4.42	0.29	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	113.63	6.26	2.09	1.56	4.17	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	221.04	9.83	3.20	5.49	4.80	0.69	2.06	0.00
clear cell carcinoma cell line:TEN	10636-108I6	134.12	5.73	2.95	1.91	1.39	0.17	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	61.14	2.56	1.10	0.73	1.28	0.00	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	3.80	0.38	0.00	0.38	0.00	0.00	0.00	4.18
colon, adult, donor1	10082-102B1	291.56	13.09	2.38	2.38	4.76	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	124.55	9.28	2.70	2.47	2.12	0.12	0.12	0.94
colon, fetal, donor1	10070-101I7	186.01	4.33	2.47	1.24	2.47	0.62	0.00	0.62
common myeloid progenitor CMP, donor1	12130-128D6	238.34	22.92	9.17	22.92	27.50	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	169.97	12.32	3.82	5.95	2.97	0.42	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	73.35	4.53	2.26	2.57	2.11	0.00	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	71.49	4.23	2.40	1.55	0.71	0.00	0.28	0.00
corpus callosum, adult, pool1	10042-101F6	116.64	3.87	1.00	1.66	2.21	0.11	0.22	1.33
cruciate ligament, donor2	10295-104G7	423.07	17.02	3.24	5.67	12.16	1.62	0.81	1.62
diaphragm, fetal, donor1	10069-101I6	321.83	9.63	3.21	2.41	4.82	0.00	0.00	3.21
diencephalon, adult	10193-103E4	49.44	1.20	0.00	1.44	1.44	0.00	0.48	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	290.55	17.18	8.21	7.95	4.62	5.39	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	103.75	12.04	4.57	6.50	3.13	0.00	1.20	0.00
ductus deferens, adult	10196-103E7	103.65	7.97	1.50	3.99	2.49	0.00	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	192.99	5.76	0.00	2.88	5.76	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	200.10	6.62	0.00	0.74	2.21	0.74	0.74	3.68
dura mater, adult, donor1	10041-101F5	185.66	25.93	11.89	7.52	6.19	2.56	0.50	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	71.29	3.55	4.00	6.22	2.66	0.00	0.22	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	47.72	4.44	3.58	2.15	1.72	0.00	0.00	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	353.94	17.27	12.33	9.87	6.17	4.93	0.62	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	292.42	20.89	6.36	10.90	5.75	3.63	0.61	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	432.87	23.77	9.26	10.81	7.72	2.16	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	483.36	17.08	5.25	13.13	6.57	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	98.55	2.68	2.35	4.36	1.68	0.67	0.34	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	236.51	18.67	6.71	7.07	4.89	0.54	0.18	1.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	314.71	17.05	6.91	5.63	5.31	0.16	1.29	0.16
epidermoid carcinoma cell line:A431	10426-106D3	207.87	29.46	13.56	7.11	5.67	1.22	0.11	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	148.26	16.50	7.92	7.26	2.53	0.88	0.33	0.00
epididymis, adult	10197-103E8	202.40	12.14	3.56	5.02	3.98	1.05	0.63	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	208.99	52.34	23.24	19.52	7.45	4.08	0.53	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	81.40	8.26	3.54	3.15	2.36	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	305.74	25.69	8.91	4.85	4.46	0.26	0.52	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	190.74	18.31	7.68	3.15	3.54	0.10	0.20	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	275.82	26.33	9.30	4.93	3.36	0.45	1.23	0.34
esophagus, adult, pool1	10015-101C6	201.53	18.79	6.69	4.78	3.72	0.21	0.64	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	36.44	3.01	1.50	1.50	1.50	0.00	0.25	0.63
eye - muscle inferior rectus, donor1	10272-104E2	222.14	12.07	2.41	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	216.73	6.31	2.10	8.42	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	217.28	8.93	4.46	4.46	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	209.81	10.32	3.44	2.29	9.17	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	144.28	14.57	0.00	8.74	4.37	1.46	0.00	4.37
eye, fetal, donor1	10054-101G9	124.07	2.80	2.54	0.76	1.02	0.00	0.76	4.07
fibrosarcoma cell line:HT-1080	10758-110E2	158.74	19.36	5.39	9.10	3.97	0.90	0.51	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	136.04	17.81	7.36	7.83	2.85	1.42	0.24	0.00
frontal lobe, adult, pool1	10040-101F4	23.83	0.94	0.47	0.66	0.38	0.00	0.00	1.22
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	441.97	32.13	15.01	16.21	7.81	1.20	0.30	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	99.39	9.97	3.66	3.38	1.74	1.01	0.37	0.55
gall bladder, adult	10198-103E9	281.03	18.11	7.73	5.07	10.86	0.24	1.21	0.72
gamma delta positive T cells, donor1	11937-126A2	4.83	0.00	0.00	1.07	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	11.95	0.00	0.75	0.37	1.12	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	379.13	23.66	9.08	9.08	9.93	0.84	1.90	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	204.25	12.57	3.48	5.22	3.09	0.19	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	39.02	3.61	1.15	3.28	1.80	0.00	0.00	0.66
gastric cancer cell line:GSS	10560-108A2	77.79	2.75	0.92	0.92	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	58.03	2.06	0.69	1.37	1.60	0.00	0.00	0.69
giant cell carcinoma cell line:LU65	10487-107B1	81.24	14.57	4.25	3.44	1.03	0.23	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	203.08	10.64	5.88	6.72	4.48	1.12	0.42	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	258.90	8.98	5.24	4.49	3.74	0.75	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	340.09	31.98	12.14	8.87	6.54	1.16	0.42	1.37
glioblastoma cell line:A172, tech_rep2	10444-106F3	342.39	32.86	11.09	9.69	8.01	1.26	0.70	2.11
glioblastoma cell line:T98G	10485-107A8	222.18	15.01	4.75	6.73	4.19	0.33	0.22	0.77
glioma cell line:GI-1	10413-106B8	151.71	14.06	7.32	5.27	3.51	1.76	0.00	1.76
globus pallidus - adult, donor10196	10175-103C4	62.69	3.64	0.00	1.46	1.46	0.00	0.00	1.46
globus pallidus, adult, donor10252	10161-103A8	74.45	1.22	0.49	0.49	1.22	0.00	0.00	2.69
globus pallidus, adult, donor10258	10367-105F7	157.46	1.37	0.00	0.00	0.00	0.00	1.37	4.11
globus pallidus, newborn, donor10223	10364-105F4	91.66	3.20	1.60	0.53	1.07	0.00	0.00	3.73
granulocyte macrophage progenitor, donor1	12131-128D7	132.15	22.02	4.89	9.79	14.68	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	0.00	0.00	0.00	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	366.39	39.04	16.64	13.76	7.36	2.56	0.32	0.32
hIPS +CCl2, biol_rep1	14383-156B9	40.86	7.80	0.92	1.84	2.75	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	43.44	5.94	0.46	1.37	1.37	0.00	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	59.90	3.86	1.29	0.64	3.22	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	80.49	7.19	0.00	1.44	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	61.73	6.86	0.69	1.37	5.49	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	43.04	0.00	0.00	1.10	3.31	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	198.27	9.77	4.88	4.60	6.61	1.15	0.57	0.00
heart - mitral valve, adult	10205-103F7	329.46	9.57	5.08	2.69	3.89	0.30	0.90	0.90
heart - pulmonic valve, adult	10206-103F8	216.24	8.63	4.45	3.14	3.66	1.05	0.78	0.78
heart - tricuspid valve, adult	10207-103F9	235.64	7.49	5.00	3.33	0.00	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	187.12	7.75	4.08	5.10	5.10	0.00	0.20	0.20
heart, adult, diseased, donor1	10051-101G6	284.03	10.65	7.66	5.11	3.83	0.00	2.55	0.00
heart, adult, pool1	10016-101C7	178.69	5.52	1.84	2.30	2.99	0.00	0.00	0.46
heart, fetal, pool1	10046-101G1	139.23	3.90	1.44	1.54	2.16	0.10	0.00	2.88
hepatic mesenchymal tumor cell line:LI90	10778-110G4	156.73	10.80	5.86	5.24	2.78	0.31	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	51.13	0.00	1.19	2.38	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	124.20	4.31	1.44	2.32	1.99	0.00	0.11	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	137.15	3.88	2.67	3.52	2.55	0.12	0.49	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	131.17	4.55	2.53	3.33	1.92	0.00	0.51	0.20
hepatoma cell line:Li-7	10484-107A7	95.65	5.34	1.89	2.89	1.22	0.22	0.22	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	35.38	3.22	0.60	2.21	2.01	0.20	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	35.01	0.95	0.95	0.00	0.95	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	39.80	0.61	0.20	0.20	0.00	0.00	0.00	3.06
hippocampus, adult, donor10258	10374-105G5	25.89	0.50	0.00	0.00	0.00	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	52.52	3.17	0.70	1.76	0.70	1.41	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	18.92	0.61	0.61	1.22	1.22	0.00	0.00	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	25.53	2.36	1.37	0.39	0.79	0.00	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	22.60	1.02	0.25	1.52	1.02	0.00	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	5.64	1.69	0.56	0.00	0.56	0.00	0.00	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	4.65	0.00	0.00	0.00	0.00	0.00	0.26	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5.31	0.38	0.38	0.00	0.76	0.00	0.00	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	12.85	1.17	0.29	0.29	0.58	0.00	0.00	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	17.88	2.15	0.43	0.00	0.00	0.00	0.22	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	32.95	0.42	2.09	0.42	0.83	0.00	0.00	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	26.05	1.42	0.47	0.47	0.47	0.00	0.00	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	35.52	2.09	1.13	0.64	1.13	0.00	0.64	1.93
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	26.26	1.35	0.00	0.00	0.67	0.00	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	25.66	1.72	0.63	0.94	1.25	0.16	0.16	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	24.56	1.97	0.00	0.00	0.98	0.00	1.47	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	17.46	2.62	0.00	0.87	3.49	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	9.93	1.34	0.00	0.00	0.38	0.00	0.00	2.10
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	12.65	1.31	0.00	0.00	0.00	0.00	0.00	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.99	1.00	0.50	1.00	1.00	0.00	0.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	13.19	0.75	0.00	0.19	0.57	0.19	0.57	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	12.73	2.27	0.91	0.91	0.45	0.00	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.29	0.00	0.00	0.63	0.31	0.00	0.00	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	31.52	1.63	0.65	0.33	0.65	0.00	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	29.32	1.16	0.29	0.87	0.58	0.00	0.00	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	34.68	1.20	2.09	0.30	1.79	0.00	0.90	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	23.83	1.29	0.92	1.66	1.11	0.00	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	29.38	2.00	0.57	1.14	0.29	0.29	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	27.77	1.22	0.41	2.86	1.22	0.00	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	24.65	1.06	0.35	0.35	0.70	0.00	0.00	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	22.81	1.90	0.63	0.32	0.63	0.00	0.63	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	20.28	2.12	0.30	0.61	0.30	0.00	0.30	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	28.96	1.03	0.52	1.55	0.52	0.00	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	22.58	0.66	0.00	0.00	0.66	0.00	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	18.73	0.51	0.26	1.03	0.51	0.00	0.26	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	53.94	3.07	0.51	1.79	0.77	0.00	0.51	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	35.59	4.54	0.76	1.51	0.00	0.00	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	72.59	4.03	0.00	1.68	2.69	0.00	0.34	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.67	1.45	0.97	1.93	0.24	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.05	2.23	0.00	1.34	0.00	0.00	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	31.22	0.49	1.46	0.00	1.95	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	8.86	1.22	0.00	0.00	0.31	0.00	0.31	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	3.25	0.00	0.00	0.00	0.00	0.00	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	3.31	0.33	0.00	0.00	0.00	0.00	0.00	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	18.06	0.55	0.55	0.00	0.00	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	19.90	0.36	0.36	0.36	1.45	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	12.81	1.42	0.00	0.00	0.00	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	35.80	2.39	2.39	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	30.47	1.63	0.41	1.49	1.63	0.00	0.14	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	30.98	2.42	0.00	1.08	2.42	0.00	0.00	1.35
immature langerhans cells, donor1	11904-125F5	1246.08	93.47	46.01	29.78	36.56	4.60	4.60	0.00
immature langerhans cells, donor2	11905-125F6	3566.97	169.52	134.66	53.86	87.13	10.30	12.67	0.00
insula, adult, pool1	10039-101F3	25.55	1.23	0.47	0.38	0.47	0.00	0.09	0.95
keratoacanthoma cell line:HKA-1	10791-110H8	204.84	19.51	7.48	8.78	2.28	2.28	0.33	0.65
kidney, adult, pool1	10017-101C8	98.12	5.11	1.80	2.70	1.80	0.10	0.10	0.30
kidney, fetal, pool1	10045-101F9	121.67	4.10	1.77	2.90	2.55	0.00	0.21	3.75
large cell lung carcinoma cell line:IA-LM	10509-107D5	281.63	17.04	11.08	10.37	8.38	2.98	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	218.84	10.92	4.01	5.94	2.07	0.41	0.69	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	178.91	10.09	3.85	2.75	1.28	2.57	0.37	0.37
left atrium, adult, donor1	10079-102A7	177.62	10.35	2.72	2.18	4.90	0.54	0.00	0.54
left ventricle, adult, donor1	10078-102A6	241.20	4.55	1.01	3.03	3.03	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	214.51	12.04	7.39	7.39	7.11	0.00	0.00	0.82
leiomyoma cell line:10964C	10569-108B2	489.66	63.95	25.51	12.57	15.81	0.00	2.87	0.00
leiomyoma cell line:15242A	10570-108B3	348.91	57.61	20.65	7.61	13.04	0.00	3.80	0.00
leiomyoma cell line:15425	10571-108B4	615.78	56.33	28.17	14.57	6.07	0.73	5.83	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	228.58	31.75	0.00	12.70	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	80.51	8.36	5.23	4.18	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	75.91	8.26	4.25	5.78	5.08	0.12	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	303.67	21.09	9.22	10.00	4.69	0.78	0.62	0.47
liposarcoma cell line:SW 872	10726-110A6	301.80	14.26	6.58	7.31	7.19	1.10	0.37	0.37
liver, adult, pool1	10018-101C9	72.93	6.32	1.94	2.76	1.46	0.00	0.00	0.65
liver, fetal, pool1	10086-102B5	142.05	4.70	1.88	4.70	1.88	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	76.41	2.48	0.87	1.02	1.02	0.00	0.00	2.04
locus coeruleus, adult, donor10252	10165-103B3	59.79	1.66	0.92	0.92	1.11	0.00	0.00	1.85
locus coeruleus, adult, donor10258	10375-105G6	48.53	2.26	0.56	1.13	1.97	0.28	0.00	0.56
locus coeruleus, newborn, donor10223	10362-105F2	46.69	1.26	0.00	0.84	0.00	0.00	0.00	1.68
lung adenocarcinoma cell line:A549	10499-107C4	85.94	4.57	2.08	2.63	1.80	0.14	0.28	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	110.99	5.52	1.38	3.45	5.52	1.38	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	296.59	14.76	5.27	6.46	4.48	1.32	0.79	0.13
lung, adult, pool1	10019-101D1	151.56	6.38	1.30	2.13	2.13	0.59	0.47	0.24
lung, fetal, donor1	10068-101I5	208.06	6.85	2.00	2.28	3.71	0.29	0.57	3.14
lung, right lower lobe, adult, donor1	10075-102A3	236.44	8.71	2.29	7.79	5.50	0.00	0.46	0.46
lymph node, adult, donor1	10077-102A5	118.81	4.26	2.37	2.37	1.89	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	94.25	1.75	0.44	1.32	3.73	0.22	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	13.89	0.30	0.15	0.00	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	236.16	20.39	5.95	6.80	1.70	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	555.43	27.08	8.44	4.44	11.54	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	332.25	18.26	6.23	2.28	7.06	0.42	0.21	0.21
mature adipocyte, donor3	12233-129G1	402.30	17.78	6.16	3.32	8.06	0.24	0.47	0.00
mature adipocyte, donor4	12234-129G2	305.86	17.64	3.95	4.21	5.00	0.79	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	99.35	4.29	1.19	1.67	0.71	0.00	0.00	1.91
medial frontal gyrus - adult, donor10196	10170-103B8	22.56	1.13	0.00	0.00	0.00	0.00	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	34.21	0.74	0.55	0.37	0.55	0.00	0.00	4.78
medial frontal gyrus, adult, donor10258	10368-105F8	14.61	0.95	0.32	0.00	0.64	0.00	0.00	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	20.90	0.00	0.43	0.00	0.85	0.43	0.00	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	26.33	1.69	0.00	0.00	0.51	0.00	0.17	2.19
medial temporal gyrus, adult, donor10252	10156-103A3	42.87	0.00	0.42	0.42	0.42	0.00	0.00	3.61
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	26.97	0.00	0.00	0.00	0.00	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	64.25	2.87	3.23	0.72	1.79	0.72	0.00	1.44
medulla oblongata - adult, donor10196	10174-103C3	104.49	1.30	0.65	0.00	3.24	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	61.61	1.55	0.62	0.77	0.15	0.00	0.15	3.10
medulla oblongata, adult, pool1	10038-101F2	63.67	4.24	1.55	1.88	1.71	0.16	0.00	1.22
medulla oblongata, newborn, donor10223	10361-105F1	84.36	2.08	0.69	0.69	0.69	0.35	0.69	1.74
medulloblastoma cell line:D283 Med	10838-111E1	94.32	3.54	2.88	3.32	4.43	0.44	0.00	3.32
medulloblastoma cell line:ONS-76	10759-110E3	290.76	19.32	8.31	11.25	6.60	1.47	0.37	0.24
melanoma cell line:COLO 679	10514-107E1	319.40	8.05	4.31	7.19	7.47	0.57	0.72	0.14
melanoma cell line:G-361	10465-106H6	354.26	35.29	12.22	12.49	12.22	1.09	1.36	0.27
meningioma cell line:HKBMM	10691-109F7	216.72	18.09	5.25	6.33	5.61	0.90	1.45	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	87.23	0.00	0.00	0.88	2.64	0.00	0.00	9.69
merkel cell carcinoma cell line:MS-1	10844-111E7	202.19	2.07	2.33	5.18	5.18	0.00	0.78	7.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	500.04	43.58	12.12	18.87	9.21	1.69	1.84	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	233.95	23.45	10.00	8.54	4.18	0.73	0.18	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	462.14	53.01	16.15	8.70	10.77	1.24	2.07	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	384.62	33.99	16.15	11.80	4.78	0.98	0.70	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	328.71	29.85	10.21	11.36	6.93	0.39	0.77	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	462.26	38.87	13.19	14.58	6.94	1.39	1.39	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	183.13	26.77	8.41	8.24	5.49	0.86	0.86	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	404.05	34.96	13.11	11.39	6.33	1.27	1.04	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	306.66	31.30	12.73	12.73	6.37	1.59	1.59	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	217.01	21.61	10.13	7.70	4.73	1.89	0.14	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	169.29	16.64	8.25	7.97	4.84	1.28	0.43	0.71
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	44.46	6.59	0.99	3.62	1.98	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	163.69	19.10	4.98	6.64	3.32	0.69	0.42	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	492.21	44.33	17.80	15.36	11.52	2.79	1.40	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	223.76	29.81	8.78	11.43	5.31	1.02	0.20	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	183.32	21.21	4.67	9.35	3.59	0.00	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	203.38	23.07	10.14	6.52	5.48	0.93	0.31	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	139.07	30.09	14.82	8.44	4.79	0.00	0.46	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	251.31	35.24	17.20	12.17	4.20	1.68	0.42	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	212.20	20.02	8.37	8.82	4.93	1.20	0.45	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	186.35	19.52	10.33	6.74	3.24	0.88	0.53	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	222.00	27.24	8.10	8.10	4.42	2.58	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	150.80	20.60	9.44	5.44	6.30	0.57	1.14	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	650.05	57.68	29.47	21.05	9.26	3.37	4.21	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	843.93	52.06	16.44	21.46	11.42	1.83	2.28	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	701.10	44.76	16.11	8.70	9.98	0.51	2.30	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	775.06	44.50	14.66	13.61	7.59	1.57	1.83	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	733.55	42.21	15.10	13.25	7.70	0.62	2.77	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	726.07	45.42	13.89	14.12	9.18	0.94	2.35	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	766.27	44.34	13.20	14.22	7.45	0.00	1.35	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	822.88	39.30	14.93	14.15	10.22	1.18	1.57	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	640.40	44.49	14.36	11.58	11.58	0.46	4.63	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	1159.29	0.00	0.00	48.30	0.00	0.00	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	922.94	53.07	19.61	16.44	14.42	0.58	4.04	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	802.72	41.50	18.74	14.50	9.15	0.22	2.23	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	813.59	45.67	18.99	13.70	9.85	0.48	2.64	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	559.53	26.40	11.00	9.53	11.00	0.00	1.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	700.85	42.63	18.80	10.74	6.04	0.34	3.36	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	670.97	37.66	13.92	13.10	7.78	0.82	2.05	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	716.07	48.54	15.03	12.89	12.46	1.29	3.01	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	828.53	57.42	30.08	5.47	10.94	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	852.22	41.32	20.66	20.66	20.66	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	681.40	45.15	17.21	8.77	11.37	0.97	5.52	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	707.12	34.92	14.55	24.73	13.09	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	884.38	51.71	22.39	21.32	10.13	0.53	5.86	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	729.45	54.79	12.27	16.36	13.08	0.00	3.27	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	696.20	52.09	11.27	16.33	11.66	0.78	2.33	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	633.82	50.37	18.89	10.49	4.20	0.00	10.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	682.51	34.77	15.90	6.95	12.92	0.99	1.99	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	710.32	14.30	9.53	14.30	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	666.49	33.21	11.86	10.08	14.23	0.00	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	749.35	45.08	12.18	9.75	10.97	1.22	2.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	459.89	27.05	54.10	0.00	27.05	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	827.83	45.60	19.63	19.63	14.57	1.27	5.07	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	232.12	20.35	4.48	4.83	4.14	0.34	1.03	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	191.28	19.34	6.45	6.45	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	263.46	35.93	3.99	7.98	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	179.08	10.33	3.44	20.66	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	162.58	10.19	4.07	3.26	4.48	0.00	0.00	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	162.86	18.27	3.18	4.77	3.18	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	159.17	10.61	2.36	2.95	3.54	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	166.14	11.22	4.36	6.23	3.12	0.00	0.62	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	175.10	10.69	5.35	5.35	4.01	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	329.97	23.65	3.55	15.37	8.28	0.00	2.37	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	333.84	28.25	5.14	10.27	5.14	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	308.40	24.09	4.13	6.20	3.44	0.00	4.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	261.26	17.32	4.95	4.45	8.41	0.00	1.98	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	254.58	16.82	10.09	4.49	5.61	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	260.15	13.36	7.00	8.27	11.45	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	269.19	16.93	6.04	5.24	9.67	0.40	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	287.84	17.44	8.72	10.90	6.54	0.00	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	311.70	21.54	3.80	7.60	10.14	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	185.71	13.96	4.86	3.64	6.07	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	284.70	13.56	13.56	0.00	13.56	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	172.15	16.47	3.29	9.06	7.41	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	208.15	12.10	4.56	3.57	3.77	0.00	0.79	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	330.66	17.20	6.49	5.19	6.17	0.00	1.62	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	337.17	17.32	6.11	12.22	10.19	0.00	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	261.52	6.96	0.77	4.64	3.09	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	387.91	63.79	23.15	26.22	12.76	2.13	0.24	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	167.27	11.12	4.87	2.55	4.40	0.46	0.00	0.70
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	324.79	47.01	17.09	8.55	17.09	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	343.39	29.49	8.12	4.21	4.73	0.72	1.03	0.00
mesothelioma cell line:Mero-25	10850-111F4	137.08	9.76	2.27	3.86	2.04	0.00	0.68	0.23
mesothelioma cell line:Mero-41	10851-111F5	433.70	45.47	11.00	8.80	8.07	0.00	2.44	1.22
mesothelioma cell line:Mero-48a	10852-111F6	692.86	73.96	28.34	30.34	16.83	1.11	2.21	0.22
mesothelioma cell line:Mero-82	10853-111F7	294.87	24.18	10.51	9.46	6.04	0.00	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	321.89	29.96	12.94	8.51	6.13	0.51	1.36	0.00
mesothelioma cell line:Mero-84	10855-111F9	442.10	26.54	6.57	4.80	4.80	0.51	1.26	0.00
mesothelioma cell line:Mero-95	10856-111G1	315.53	30.44	12.22	6.63	7.87	0.83	0.83	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	315.39	27.99	10.77	7.12	5.47	0.83	1.33	0.50
mesothelioma cell line:NCI-H226	10846-111E9	295.02	50.68	20.27	16.11	7.42	0.00	1.09	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	284.93	36.04	11.96	9.57	7.17	0.00	1.02	0.17
mesothelioma cell line:NCI-H28	10845-111E8	237.42	25.19	8.91	7.63	6.87	0.00	0.25	0.25
mesothelioma cell line:No36	10857-111G2	248.89	19.90	7.18	5.22	7.50	1.30	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	390.17	39.29	18.15	14.09	11.11	0.81	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	57.96	3.45	1.92	2.49	2.49	0.38	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	71.56	4.15	0.98	1.34	2.32	0.61	0.12	0.12
migratory langerhans cells, donor3	11903-125F4	31.23	1.26	1.08	0.90	2.69	0.54	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	132.22	7.84	3.26	3.92	4.57	1.96	1.63	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	171.88	13.99	6.57	12.72	3.39	1.91	1.27	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	413.95	46.99	24.88	13.82	9.44	1.38	0.00	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	262.22	17.51	5.90	6.85	4.76	0.19	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	36.96	2.40	0.37	0.92	1.29	0.55	0.00	0.18
myeloma cell line:PCM6	10474-106I6	10.67	0.00	0.00	0.00	0.40	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	429.17	25.36	13.70	10.15	8.62	1.01	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	674.13	67.28	19.22	22.56	10.98	0.59	0.98	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	108.19	13.37	6.91	4.12	2.34	0.11	0.00	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	91.63	13.09	6.32	3.09	1.99	0.07	0.29	0.37
nasal epithelial cells, donor2	12227-129F4	209.20	27.05	5.52	9.38	7.18	0.55	0.55	0.00
neuroblastoma cell line:CHP-134	10508-107D4	2.76	0.00	0.00	0.00	0.00	0.00	0.00	1.15
neuroblastoma cell line:NB-1	10539-107G8	219.64	16.46	5.05	11.79	10.66	0.00	0.75	1.50
neuroblastoma cell line:NBsusSR	10607-108F4	8.44	0.21	0.00	0.00	0.00	0.00	0.00	0.42
neuroblastoma cell line:NH-12	10555-107I6	27.39	0.37	0.75	0.56	0.37	0.00	0.00	2.80
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	108.89	1.66	0.71	0.47	3.32	0.00	0.71	6.41
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	162.82	3.17	1.11	1.58	3.96	0.16	0.79	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	28.18	1.81	0.81	0.60	1.41	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	120.80	2.54	0.00	0.64	1.91	0.00	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	431.72	37.53	14.64	16.77	9.58	1.60	1.06	0.53
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	92.06	8.01	2.40	4.00	4.80	0.00	0.00	2.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	591.84	32.70	13.79	11.54	10.58	1.60	2.89	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	369.71	27.06	6.83	12.61	10.77	1.05	3.42	1.05
nucleus accumbens, adult, pool1	10037-101F1	32.53	0.56	0.47	0.47	0.56	0.00	0.09	1.12
occipital cortex - adult, donor10196	10172-103C1	41.21	0.00	0.00	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	53.14	1.34	0.27	0.54	0.27	0.00	0.00	7.78
occipital cortex, newborn, donor10223	10355-105E4	48.04	2.91	0.36	0.73	2.18	1.09	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	40.41	0.79	0.52	1.05	2.10	0.00	0.26	1.84
occipital lobe, fetal, donor1	10073-102A1	6.87	0.00	0.00	0.00	0.00	0.00	0.43	14.59
occipital pole, adult, pool1	10036-101E9	26.10	1.97	0.55	0.87	0.63	0.00	0.00	1.42
olfactory region, adult	10195-103E6	41.84	1.53	0.19	0.19	1.53	0.00	0.00	1.72
optic nerve, donor1	10277-104E7	224.12	12.01	4.00	8.00	8.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	197.06	36.34	13.78	10.94	2.96	1.48	0.11	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	47.40	3.02	0.55	1.24	0.82	0.00	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	215.04	15.75	7.11	3.89	3.89	0.85	0.68	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	104.88	8.55	2.19	4.62	2.19	0.81	0.12	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	430.07	38.51	12.05	14.40	11.76	0.29	0.29	1.18
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	39.24	7.47	4.67	1.87	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	261.89	12.30	4.88	7.63	7.63	2.12	0.42	1.06
ovary, adult, pool1	10020-101D2	227.03	6.38	2.88	2.01	2.36	0.26	0.00	1.40
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	79.74	6.42	3.48	3.12	2.93	0.55	0.37	0.18
pancreas, adult, donor1	10049-101G4	78.07	4.70	0.00	1.88	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	85.26	3.91	1.68	1.12	0.84	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	287.90	21.12	10.39	7.15	6.13	0.68	1.53	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	142.73	11.92	6.13	2.32	3.31	0.83	0.50	0.17
paracentral gyrus, adult, pool1	10035-101E8	27.55	1.10	0.64	0.37	0.73	0.00	0.00	1.28
parietal cortex, adult, donor10258	10373-105G4	22.75	4.40	0.00	2.20	4.40	0.00	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	52.67	1.88	0.00	0.00	0.00	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	29.93	0.29	0.86	0.57	0.57	0.00	0.29	5.99
parietal lobe, adult, pool1	10034-101E7	28.99	1.32	0.53	0.62	0.70	0.00	0.00	1.76
parietal lobe, fetal, donor1	10072-101I9	16.49	0.97	0.00	0.00	0.00	0.97	0.00	3.88
parietal lobe, newborn, donor10223	10356-105E5	44.86	2.99	1.12	1.12	2.24	0.00	0.37	1.12
parotid gland, adult	10199-103F1	157.25	6.78	0.00	1.23	1.23	0.00	1.23	0.00
penis, adult	10200-103F2	382.96	17.72	5.91	7.52	3.76	2.15	1.61	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	102.08	1.49	1.30	0.74	1.30	0.19	0.19	1.12
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	126.46	8.30	2.91	2.48	2.62	0.58	0.29	0.00
pineal gland - adult, donor10196	10179-103C8	56.12	3.87	1.29	2.58	1.29	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	37.90	1.18	0.59	0.00	0.00	0.00	0.00	2.37
pineal gland, adult, donor10258	10377-105G8	40.76	1.25	0.00	0.00	0.63	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	62.73	8.09	1.01	2.02	1.01	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	68.27	0.52	0.52	0.52	1.04	0.00	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	46.82	2.55	0.85	1.70	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	263.06	9.35	3.55	3.98	3.33	0.32	0.11	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	37.48	0.66	0.26	0.53	1.06	0.13	0.00	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	335.09	16.34	7.47	5.76	3.58	5.60	0.16	0.31
pons, adult, pool1	10033-101E6	37.01	2.50	0.69	0.77	1.12	0.00	0.00	1.98
postcentral gyrus, adult, pool1	10032-101E5	27.55	1.74	0.35	0.87	0.78	0.00	0.09	1.22
promyelocytes/myelocytes PMC, donor1	12132-128D8	20.91	2.09	2.09	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	222.57	21.27	8.74	9.91	7.72	1.75	0.29	0.58
prostate cancer cell line:PC-3	10439-106E7	204.92	22.14	9.26	7.62	5.08	0.18	0.36	0.36
prostate, adult, pool1	10022-101D4	133.50	5.80	1.45	1.18	1.27	0.54	0.36	1.09
putamen, adult, donor10196	10176-103C5	39.19	0.71	0.71	1.18	0.24	0.00	0.24	1.18
putamen, adult, donor10252	10152-102I8	43.14	0.00	0.00	1.96	1.96	0.00	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	2.19	0.00	0.00	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	19.09	0.24	0.00	0.24	0.48	0.00	0.00	1.21
putamen, newborn, donor10223	10365-105F5	36.73	3.00	0.00	0.75	0.00	1.50	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	127.43	3.49	1.75	1.16	1.16	0.00	0.00	0.87
rectum, fetal, donor1	10067-101I4	338.01	4.17	1.39	4.17	8.35	1.39	1.39	8.35
renal cell carcinoma cell line:OS-RC-2	10411-106B6	192.28	13.36	5.72	5.94	2.76	0.42	0.21	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	125.92	1.66	0.83	2.07	1.66	0.41	0.83	0.00
retina, adult, pool1	10030-101E3	153.27	6.06	2.98	2.78	2.88	0.10	0.10	2.78
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	0.26	0.00	0.00	0.00	0.26	4.68
rhabdomyosarcoma cell line:KYM-1	10787-110H4	173.11	11.07	6.27	7.75	5.16	0.00	0.49	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	128.79	2.53	1.12	1.12	1.41	0.00	0.28	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	256.91	26.52	7.58	9.85	3.79	0.76	0.76	2.27
salivary acinar cells, donor1	11771-123I7	175.61	22.98	10.20	9.71	4.69	0.16	0.32	0.65
salivary acinar cells, donor2	11772-123I8	300.98	29.05	10.46	11.57	7.99	0.14	0.41	0.96
salivary acinar cells, donor3	11773-123I9	248.93	31.78	9.93	6.62	2.65	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	150.42	10.30	4.00	1.14	1.14	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	175.45	32.71	11.30	9.44	4.81	1.35	0.67	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	174.68	32.09	12.34	11.40	5.64	0.59	0.12	0.00
seminal vesicle, adult	10201-103F3	101.58	7.41	2.12	3.17	1.06	0.00	0.00	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	490.22	27.94	10.20	8.02	7.77	4.86	2.19	0.73
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	384.24	22.90	7.30	6.04	4.03	1.01	1.01	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	298.05	28.10	11.04	6.02	5.02	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	104.23	4.16	2.15	1.61	0.81	0.00	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	458.25	30.51	13.26	9.95	8.18	0.55	0.44	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	322.95	18.19	8.00	5.68	5.29	0.90	0.39	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	121.30	6.38	2.13	1.42	1.42	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	122.70	8.88	3.96	2.40	2.64	0.24	0.00	0.48
skeletal muscle, fetal, donor1	10066-101I3	337.69	15.08	6.03	10.05	4.02	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	508.89	13.57	6.79	6.79	13.57	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	433.02	16.41	4.42	5.05	3.79	0.00	1.89	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	8.00	0.67	0.33	0.00	0.67	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	26.79	3.15	0.32	1.26	0.63	0.32	0.32	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	33.15	2.31	0.77	1.35	1.54	0.00	0.00	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	64.12	5.11	0.99	1.81	2.47	0.00	0.00	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	20.11	0.32	0.16	0.32	0.16	0.16	0.00	1.61
small cell lung carcinoma cell line:WA-hT	10562-108A4	96.97	2.18	0.87	2.40	1.74	0.65	0.22	2.40
small intestine, adult, pool1	10024-101D6	139.03	8.60	2.87	2.51	2.39	0.12	0.12	0.36
small intestine, fetal, donor1	10064-101I1	132.92	2.46	0.98	2.21	0.98	0.49	0.25	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	34.88	2.05	0.00	3.08	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	207.28	8.79	2.07	4.39	2.33	1.29	0.78	1.03
somatostatinoma cell line:QGP-1	10781-110G7	46.90	4.02	1.07	2.68	1.61	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	52.53	1.84	1.61	0.46	0.46	0.23	0.46	1.15
spinal cord, adult, donor10252	10159-103A6	42.98	0.79	1.18	0.39	0.39	0.00	0.39	1.58
spinal cord, adult, donor10258	10369-105F9	38.74	1.38	0.00	0.00	1.38	0.00	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	159.17	3.66	2.44	2.44	1.83	0.00	0.61	3.05
spinal cord, newborn, donor10223	10359-105E8	47.30	0.92	0.46	0.00	1.38	0.00	0.00	3.21
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	304.09	28.68	12.70	14.19	3.88	0.30	0.75	0.90
spleen, adult, pool1	10025-101D7	81.61	2.97	1.54	1.76	1.65	0.00	0.00	0.11
spleen, fetal, pool1	10044-101F8	129.27	3.81	1.59	2.15	2.38	0.08	0.16	0.79
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	126.91	4.45	3.93	3.00	3.93	0.10	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	77.28	3.04	1.52	1.71	0.95	0.95	0.19	1.33
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	162.50	10.83	5.59	4.54	5.59	0.00	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	272.09	25.02	11.73	9.77	3.13	3.52	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	248.87	24.31	12.49	12.16	5.29	1.46	0.23	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	295.25	5.08	2.54	4.24	2.97	0.00	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	296.57	33.42	13.96	15.23	6.35	1.69	0.00	0.00
stomach, fetal, donor1	10062-101H8	227.48	21.36	9.61	6.41	6.41	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	151.54	5.13	1.14	1.71	1.14	0.00	0.00	1.14
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	75.19	1.25	0.42	0.62	0.42	0.00	0.21	3.32
substantia nigra, adult, donor10258	10371-105G2	35.69	1.03	0.00	0.00	0.52	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	97.51	5.65	0.00	0.71	1.41	0.00	0.00	2.83
synovial sarcoma cell line:HS-SY-II	10441-106E9	70.38	4.36	1.15	1.15	2.98	0.00	0.00	0.46
temporal lobe, adult, pool1	10031-101E4	32.64	2.20	0.68	1.02	0.76	0.00	0.00	1.19
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	7.83	0.00	0.00	0.00	0.00	0.00	0.00	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	25.49	2.20	0.00	0.88	1.32	0.00	0.44	3.08
tenocyte, donor1	11763-123H8	909.41	46.43	15.71	16.06	7.33	0.00	3.84	1.75
tenocyte, donor2	11765-123I1	639.78	33.19	11.45	11.06	5.72	0.38	4.58	1.14
tenocyte, donor3	11768-123I4	1008.21	61.16	15.57	13.71	10.01	0.00	3.71	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	80.73	6.80	2.89	3.91	4.25	0.00	0.34	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	72.91	1.39	1.08	1.70	0.92	0.15	0.15	0.46
teratocarcinoma cell line:PA-1	10807-111A6	96.40	4.96	2.17	1.86	2.17	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	193.34	13.84	6.47	6.73	4.82	0.25	0.25	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	167.15	4.92	2.27	2.27	2.27	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	163.81	15.27	7.85	5.56	5.34	1.09	0.22	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	54.72	2.61	1.63	0.98	4.23	0.00	0.33	0.00
testis, adult, pool1	10026-101D8	138.62	7.19	3.65	3.33	2.47	0.32	0.43	0.54
testis, adult, pool2	10096-102C6	116.38	8.12	0.90	0.90	4.51	0.00	0.90	0.45
thalamus - adult, donor10196	10168-103B6	78.38	1.10	1.10	0.00	1.10	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	64.70	0.78	0.31	0.16	0.63	0.00	0.16	3.75
thalamus, adult, donor10258, tech_rep1	10370-105G1	72.36	1.54	0.00	0.00	3.08	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	56.49	1.48	0.33	0.49	1.48	0.33	0.16	1.81
thalamus, newborn, donor10223	10366-105F6	33.37	1.73	0.00	0.00	0.00	0.00	0.00	1.15
throat, adult	10209-103G2	289.87	12.73	6.74	3.25	3.50	0.00	2.25	0.25
throat, fetal, donor1	10061-101H7	233.71	7.31	3.35	2.74	4.88	0.30	0.91	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	14.51	1.39	0.79	0.40	0.40	0.00	0.20	1.59
thymus, adult, pool1	10027-101D9	31.32	3.98	1.39	1.89	1.69	0.10	0.00	0.10
thymus, fetal, pool1	10043-101F7	43.74	2.81	1.25	1.45	0.73	0.00	0.10	0.73
thyroid carcinoma cell line:KHM-5M	10776-110G2	220.45	19.28	11.04	7.45	4.52	1.20	0.40	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	243.06	32.83	15.37	11.59	8.66	2.79	0.14	0.70
thyroid, adult, pool1	10028-101E1	121.12	3.36	1.59	1.77	0.84	0.00	0.47	0.47
thyroid, fetal, donor1	10060-101H6	383.10	6.06	2.37	3.16	5.01	0.00	0.00	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	563.57	33.88	6.16	9.24	15.40	3.08	0.00	0.00
tongue, adult	10203-103F5	444.46	39.77	9.30	10.47	7.44	0.93	1.86	0.47
tongue, fetal, donor1	10059-101H5	362.96	13.40	5.91	4.73	5.52	0.00	1.18	1.58
tonsil, adult, pool1	10047-101G2	150.76	15.73	5.51	4.81	2.70	0.40	0.70	0.80
trachea, adult, pool1	10029-101E2	132.27	7.85	2.94	2.78	1.96	0.08	0.08	0.49
trachea, fetal, donor1	10058-101H4	325.45	5.00	2.69	2.31	3.46	0.00	1.54	3.46
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	452.41	49.24	20.19	17.01	12.75	1.42	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	73.45	6.99	2.84	2.53	2.13	0.10	0.20	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	296.45	58.44	23.97	18.33	9.56	3.92	0.47	1.41
tridermal teratoma cell line:HGRT	10694-109G1	292.99	38.05	13.32	13.32	11.42	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	243.29	24.38	6.69	7.79	4.83	1.61	0.34	0.25
umbilical cord, fetal, donor1	10057-101H3	267.07	10.43	10.43	2.09	0.00	4.17	0.00	2.09
uterus, adult, pool1	10100-102D1	341.94	12.97	3.07	3.41	4.27	1.19	0.85	2.05
uterus, fetal, donor1	10055-101H1	315.86	11.77	4.10	4.61	7.17	0.00	1.02	2.05
vagina, adult	10204-103F6	178.35	3.88	0.00	1.29	3.23	0.00	0.00	1.29
vein, adult	10191-103E2	181.93	6.80	1.53	1.10	3.51	0.00	0.88	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	121.23	5.61	2.67	3.47	3.47	0.00	0.00	0.00